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ABSTRACT 
Natural products continue to be an important source of therapeutically-relevant 
compounds. With the advent of inexpensive genome sequencing it has become apparent that 
bacteria produce a larger array of natural products than was previously believed. This new wealth 
in sequence data has potential to be helpful for the discovery of novel compounds by using 
genome mining. Although strategies of genome mining have become more efficient and capable 
of identifying novel biosynthetic gene clusters, it remains difficult to correlate gene clusters with 
natural products. In this dissertation I discuss limitations with the current methods of genome 
mining and correlating individual natural products with gene clusters. Furthermore, I characterize 
a rapidly growing family of natural products, the thiazole/oxazole-modified microcins (TOMMs), 
and discuss novel methods used to correlate the gene clusters to natural products from this family 
of metabolites. In chapter 2, I establish the sequence diversity and structural capability of bacteria 
and archaea to produce TOMM natural products. This genome mining characterization was used 
to identify nine novel classes of TOMMs, including one class from archaeal producers. In chapter 
3, I discuss the utilization of genetic techniques to identify and isolate the TOMM natural product 
from the archaeal species Sulfolobus acidocaldarius. I demonstrate that although genetic 
manipulation has been previously used for the identification of natural products, comparative 
metabolomics is difficult to use for routine identification of low-abundance natural products such 
as the TOMM from S. acidocaldarius. Very few methods have been created to identify natural 
products from particular gene clusters. Therefore, in chapter 4, I discuss the creation of a novel 
method for the rapid identification of natural products following bioinformatics prioritization of 
antibiotic producing strains. This method utilizes the combination of genome mining and the 
chemical reactivity of natural products to discover new compounds. Dehydrated amino acids are 
modified residues commonly found in natural products such as TOMMs. I utilize the mild 
electrophilic chemical reactivity of dehydrated amino acids to label these natural products using a 
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soft nucleophilic probe. These labeled natural products were easily detected using comparative 
mass spectrometry. Bacterial strains were prioritized by the genome mining established in chapter 
2 to reduce the screening time to find a novel natural product. This dissertation presents the 
addition of novel genome mining and natural product discovery techniques to increase the 
discovery and production of therapeutically-relevant compounds.  
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CHAPTER I: INTRODUCTION 
 
I am grateful to Joel Melby, Brian San Francisco, and Jonathan Tietz for critically editing 
this chapter. 
 
1.1 Genome Mining for Natural Product Discovery 
Natural products have historically been the most prolific source of antibiotics (Newman, 
et al. 2012). Nearly 80% of all approved antibacterial are natural products or derivatives thereof 
(Newman, et al. 2012). Some notable examples include ciprofloxacin (DNA synthesis inhibitor) 
(Wise, et al. 1983), chloramphenicol (protein synthesis inhibitor) (Gottlieb, et al. 1954), and 
rifampicin (RNA polymerase inhibitor) (Sensi, et al. 1959). Traditionally, scientists have relied 
on bioactivity-based screening to identify fractions of bacterial crude extracts for compounds with 
antibiotic properties. Difficulties intrinsic to this discovery method, including frequent 
rediscovery and necessarily large, expensive screening efforts, have led most large 
pharmaceutical companies to reduce or eliminate their antibiotic discovery efforts (Lewis 2013, 
Payne, et al. 2007). This has coincided with the emergence of multidrug-resistant strains of 
pathogenic bacteria, accelerated by the overuse and misuse of antibiotics. It has been estimated 
that the U.S. alone spends $20 billion annually on direct healthcare costs to treat patients with 
antibiotic-resistant bacterial infections (U.S. Department of Health and Human Services 2013). 
Therefore, it is imperative that novel methods for identifying antibacterial therapies be developed. 
With the maturation of genome sequencing, it has become apparent that the collection of 
characterized natural products represents only a fraction of the true genomic potential of microbes 
(Bentley, et al. 2002). Consequently, genome mining is emerging as a powerful method for the 
identification and isolation of novel compounds (Bachmann, et al. 2014, Challis 2008, Deane, et 
al. 2014, Doroghazi, et al. 2014, Doroghazi, et al. 2013, Velasquez, et al. 2011).  
Genome sequencing has profoundly changed the discovery process of natural products by 
providing access to the biosynthetic potential of microbes prior to the intense traditional 
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screening process (Bachmann, et al. 2014, Challis 2008, Van Lanen, et al. 2006). The recognition 
that even the well-characterized bacterium Streptomyces coelicolor harbors many additional 
biosynthetic pathways beyond its characterized natural products (Bentley, et al. 2002) led to the 
wide acceptance that many microbes encode a plethora of biosynthetic gene clusters with 
unknown natural products (Baltz 2008, Fischbach, et al. 2009, Jensen, et al. 2014). This 
observation implies that many microbial natural products are either not produced in laboratory 
conditions or are not being detected using the traditional discovery techniques. Genome mining 
provides an approach wherein strains can be prioritized for their biosynthetic potential, while 
providing researchers with information used to avoid re-isolating known compounds, forecast the 
properties of the expected compounds, or even, in some cases, make exact predications of the 
final natural product structure, all of which enhance the discovery platform. Many bioinformatics 
tools have emerged to characterize novel biosynthetic pathways (Blin, et al. 2013, de Jong, et al. 
2006, Li, Qu, et al. 2012, Mohimani, et al. 2014), the majority of which have focused on two 
common, predictable classes of natural products: type I polyketide synthases (PKS) and 
nonribosomal peptide synthetases (NRPS). Recently, genome characterization of ribosomally 
produced natural products (RiPPs) has shown that the biosynthetic and structural potential of this 
class is much more diverse than originally believed, meaning increased effort should be directed 
at bioinformatic evaluation of these types of molecules (Lee, et al. 2008, Letzel, et al. 2014, 
Velasquez, et al. 2011). 
1.2 Ribosomally Synthesized and Post-Translationally Modified Peptide Natural Products 
 Bacterial natural product research over the past century has largely been focused on 
nonribosomal peptide (NRP) and polyketide (PK) natural products. There are many examples of 
NRP and PK natural products or derivatives that have been approved as antibiotics (Fischbach, et 
al. 2006). Additionally, genome sequencing combined with enzymatic characterization of the 
PKS and NRPS machinery has bolstered the genome mining approach for NRP and PK natural 
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product discovery (Fischbach, et al. 2006). More recently, genome sequencing has revealed 
another widely distributed subgroup of natural products, RiPPs (Haft, et al. 2010, Lee, et al. 
2008, Letzel, et al. 2014, Maksimov, et al. 2014, Velasquez, et al. 2011). RiPPs comprise both a 
diverse chemical and genetic landscape, including but not limited to lanthipeptides, 
thiazole/oxazole-modified microcins (TOMMs), lasso peptides, and linaridins. In all cases a 
ribosomally produced precursor peptide undergoes modification by a set of tailoring enzymes 
(Figure 1.1) (Arnison, et al. 2013, Dunbar, et al. 2013). These modifications include cyclizations, 
dehydrations, methylations, and disulfide bond formations, among others (Arnison, et al. 2013). 
The precursor peptide sequence and posttranslational modifications govern the structure of the 
final product; this template-based biosynthetic strategy simplifies structural predictions from 
genomic information. Of the characterized RiPPs, all show diverse combinations of chemical 
modifications and structures leading to a plethora of bioactivities. This simple peptide-oriented 
strategy leads to highly evolvable biosynthetic pathways with the capability to produce 
structurally diverse compounds (variable templates) using minimal genetic space. Additionally, 
microbes can further evolve the natural product with the addition or deletion of modification 
enzymes (variable tailoring).   
1.3 Thiazole/Oxazole-Modified Microcins (TOMMs) 
 Thiazole/oxazole-modified microcins (TOMMs) comprise a subclass of RiPPs 
characterized by the presence of nitrogeneous five-membered heterocycles derived from cysteine, 
serine, and threonine residues (Li, et al. 1996, Mitchell, et al. 2009). The hallmark of a TOMM 
gene cluster is the presence of a cyclodehydratase (termed the C and D protein complex if 
separate or the CD fusion protein if merged) that executes an ATP-dependent cyclization of 
cysteine, serine, and threonine residues to form the thiazoline and (methyl)oxazoline (azoline) 
heterocycles (Figure 1.1) (Dunbar, et al. 2014, Dunbar, et al. 2012, Dunbar, et al. 2013). Some 
TOMM gene clusters also contain an FMN-dependent dehydrogenase (termed the B protein) that 
catalyzes the oxidation of azoline heterocycles to their respective azoles (Melby, et al. 2014). 
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These heterocycles restrict the conformational flexibility to provide the peptide with a rigid 
structure, which ultimately endows the final product with a specific activity. TOMM biosynthetic 
gene clusters often contain additional tailoring enzymes that increase structural diversity within 
the TOMM family.  As with many bacterial natural product classes, the enzymes responsible for 
heterocycle formation are often clustered in biosynthetic pathways, making them easily 
discernable by genome mining (Figure 1.1) (Lee, et al. 2008, Velasquez, et al. 2011). 
 TOMM biosynthetic genes clusters have been identified in both bacterial and archaeal 
genomes (Lee, et al. 2008). There are many categories of TOMM clusters, defined by the type of 
natural product produced. Examples of studied TOMMs include microcin B17 (DNA gyrase 
inhibitor) (Belshaw, et al. 1998), streptolysin S (cytolysin) (Mitchell, et al. 2009, Molloy, et al. 
2011), thiopeptides (ribosome inhibitor) (Just-Baringo, et al. 2014), and the cyanobactins 
(anticancer properties)(Schmidt, et al. 2009) (Figure 1.2). Although some TOMMs have been 
extensively characterized, the majority of TOMMs are unknown and could be an unexploited 
reservoir of therapeutically useful compounds (Melby, et al. 2011).  
1.4 TOMM Machinery for Genome Mining 
Genome mining for TOMMs requires an understanding of the prevalence and function of 
the genes essential for their biosynthesis. Progress in recent years has shed light on these 
biosynthetic pathways and the biosynthetic enzymes responsible for natural product maturation. 
1.4.1 Microcin B17 
Microcin B17 (MccB17), the first characterized TOMM, is a DNA gyrase inhibitor 
produced by select E. coli strains. In a pioneering study, the proteins responsible for MccB17 
production were discovered by genome mining and reconstituted, allowing for the general 
biosynthetic route for the production of TOMMs to be determined (Li, et al. 1996). In this study it 
was shown that the trimeric complex composed of McbB (C protein), McbC (B protein), and 
McbD (D protein) installed thiazole and oxazole moieties onto the McbA precursor peptide. This 
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seminal publication as well as follow up studies introduced the minimal set of modification 
enzymes necessary for the production of TOMMs. The functions of these enzymes have been 
further elucidated in other TOMM systems. The D protein was demonstrated to catalyze the 
cyclodehydration reaction to convert a subset or all Cys, Ser, and Thr residues to thiazolines and 
(methyl)oxazolines (Dunbar, et al. 2014, Dunbar, et al. 2012, Dunbar, et al. 2013). The C protein 
is responsible for the recognition of the peptide substrate and the regulation of the D protein 
activity (Dunbar, et al. 2013). In MccB17 biosynthesis a third protein is necessary for the 
installation of heterocycles. The B-protein is a flavin mononucleotide (FMN)-dependent 
dehydrogenase that oxidizes the azoline heterocycles to azoles. 
1.4.2 Streptolysin S 
Although the β-hemolytic phenotype from group A Streptococcus was first identified 
over a century ago, the genes responsible for the biosynthesis of streptolysin S (SLS), a toxin that 
causes the phenotype, were not determined until 1998 (Betschel, et al. 1998, Nizet, et al. 2000). 
In a transposon mutational study, the entire SLS-associated gene (sag) operon was discovered. 
Similar to MccB17 production, the biosynthetic gene cluster is composed of SagBCD enzymes 
that are required for the posttranslational modification of the precursor peptide, SagA. The Sag 
enzymes are similar enough to the MccB17 enzymes that they are capable of modifying the 
McbA precursor peptide to produce an active gyrase inhibitor (Mitchell, et al. 2009). 
Characterization of these two clusters led to the discovery that it was precursor sequence and not 
modification enzymes that dictated final product activity (Lee, et al. 2008, Mitchell, et al. 2009). 
Furthermore, the discovery of two similar clusters in disparate organisms prompted researches to 
use genome mining to identify similar cluster with homologs of the B, C, and D proteins, which 
lead to the identification of the entire family of TOMM natural product gene clusters (Velasquez, 
et al. 2011). Although the MccB17 and Sag operons require only the BCD enzymes for 
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modification, characterization of other TOMM clusters revealed that many clusters have 
additional modification enzymes to enhance the chemical structures.   
1.4.3 Cyanobactins 
Cyanobactins are a family of small macrocyclized compounds produced by 
cyanobacteria. In a pioneering study, it was determined that cyanobactins were not produced by a 
sea squirt, but rather a bacterial symbiont, Prochloron didemni (Schmidt, et al. 2005). 
Furthermore, it was identified that these cyanobacterial natural products were indeed ribosomally 
produced and heterocycles were installed in a similar manner to MccB17 production. 
Cyanobactins have many activities including antitumor, cytotoxic, and multi-drug reversing 
effects (Sivonen, et al. 2010). A key difference between cyanobactins and other TOMMs is that 
after installation of the heterocycles, the cyanobactin peptides are cleaved from the precursor by 
not one but two proteases. In the patellamide biosynthetic cluster, PatA was shown to cleave the 
N-termini and PatG the C-termini. PatG also catalyzes the head-to-tail cyclization of the peptides. 
The permissive substrate tolerance of PatG was demonstrated through the characterization of 
macrocyclization of synthetic substrates with varying lengths and amino acid compositions 
(Agarwal, et al. 2012, Lee, et al. 2009). 
1.4.4 Thiopeptides 
Thiopeptides are a family of TOMMs with highly modified macrocylic core peptides 
defined by a central pyridine ring. Although the first of this class was described in 1948 (Su 
1948), the biosynthetic machinery responsible for producing thiopeptides was not determined 
until 2009, when four independent research groups reported the genes responsible for the 
production of multiple thiopeptides; at this time it became apparent that thiopeptides were 
manufactured in a similar fashion to linear TOMMs such as microcin B17 (Crone, et al. 2012, 
Gomez-Escribano, et al. 2012, Hou, et al. 2012, Huo, et al. 2012). Furthermore, nearly all 
identified thiopeptide gene clusters contain a lanthipeptide-like dehydratase that simply 
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dehydrates, rather than cyclodehydrates, select Ser and Thr residues to form dehydroalanine 
(Dha) and dehydrobutyrines (Dhb) (Li, et al. 2010, Ortega, et al. 2014). Another TOMM, 
goadsporin – a promoter of secondary metabolism and morphogenesis in actinomycetes – also 
contains enzymes to install Dha and Dhb residues, but is not macrocyclized like the thiopeptides.   
It is widely believed that in thiopeptide biosynthesis two dehydroalanines undergo an 
enzyme-catalyzed formal [4+2] cycloaddition to form the central 6-membered nitrogen ring 
which can be found in various oxidation states. This was first supported by feeding experiments, 
and confirmed by the identification of the ‘hetero-Diels-Alderase’ enzyme responsible for the 
reaction (TclM in thiocillin biosynthesis) (Bowers, et al. 2010). 
1.4.5 Plantazolicin 
Plantazolicin (PZN) is a TOMM from the soil bacterium Bacillus amyloliquefaciens 
FZB42 recently discovered using gene deletions and mass spectrometry. It has highly 
discriminating antibacterial activity against Bacillus anthracis, the causative agent of anthrax 
(Scholz, et al. 2011). The PZN precursor peptide is modified by an extremely specific S-
adenosylmethionine (SAM)-dependent methyltransferase present in the gene cluster (Lee, et al. 
2013, Molohon, et al. 2011). The X-ray crystal structure of the methyltransferase revealed a deep 
and narrow cavity for substrate binding, supporting the specificity of the enzyme for modification 
only of PZN derivatives (Lee, et al. 2013).  
1.4.6 Bottromycin 
 Bottromycin is a TOMM with potent antimicrobial activity against methicillin resistant 
Staphylococcus aureus (MRSA) and vancomycin resistant Enterococcus (VRE). Characterized 
bottromycin gene clusters contain two genes with a YcaO-like domain similar to the D proteins, 
but they contain no distinguishable C protein, which is used in other TOMM biosynthesis to 
potentiate the D protein’s activity (Crone, et al. 2012, Gomez-Escribano, et al. 2012, Hou, et al. 
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2012, Huo, et al. 2012). This is the first example of a TOMM that does not contain both a C and 
D protein, complicating genome mining for TOMMs.   
There are two groups of YcaO domain-containing proteins (homologs of D proteins not 
associated with a C protein): the non-TOMM YcaOs and the TfuA-associated non-TOMM 
YcaOs. The latter is found co-occurring in clusters with a gene encoding for the protein TfuA, 
which has been implicated in trifolitoxin production (Breil, et al. 1996). Although all of these 
YcaO proteins contain the canonical ATP-binding pocket, the substrate of the non-TOMM YcaOs 
are unknown (Dunbar, et al. 2014). With the elucidation of bottromycin biosynthesis, it became 
apparent that YcaO domain-containing proteins have the potential to make natural products even 
without a canonical C protein, lending previously unanticipated potential to many uncharacterized 
‘stand-alone’ YcaO proteins.  
1.5 Natural Product Discovery Methods Potentiated by Genome Mining 
While genome mining has become an extremely useful tool for natural product discovery, 
it has also become apparent that finding natural products produced by certain gene clusters is 
much more difficult than identifying the gene clusters of interest. This has created a roadblock in 
the discovery process, generating an overabundance of gene clusters with unknown natural 
products. It is imperative to develop novel strategies to quickly identify natural products from 
predicted gene clusters in order to realize the full potential of genome mining-based natural 
product discovery. Therefore many research groups have begun to introduce strategies to connect 
genome clusters to natural products.  
1.5.1 Gene deletions and heterologous production using comparative metabolic profiling 
 Perhaps the most definitive method to establish the connection between genes and natural 
products is through the genetic deletion of production enzymes. Traditionally, comparison of the 
wild type strain with the genetic deletion mutant, using metabolomics (using mass spectrometry) 
or bioactivity, allows for the identification of natural products (Figure 1.3 A). Additionally, the 
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discovery of plantazolicin highlights a secondary use for genetic deletions, in which deletions of 
other natural product clusters were used to reduce the interfering mass spectrometry signal from 
abundant natural products, thus unmasking the less abundant natural product: plantazolicin. 
Furthermore, genetic deletions of the necessary modification machinery for the production of 
plantazolicin were made to confirm the gene cluster (Scholz, et al. 2011).  
 In the event that the original host is not genetically tractable, the genes from a 
biosynthetic cluster can instead be transferred to a genetically tractable host for the production 
and identification of natural products. Recently, genome mining identified the gene cluster 
responsible for the production of the lasso peptide natural products including, caulosegnins I-III 
(Hegemann, Zimmermann, Xie, et al. 2013, Maksimov, et al. 2014, Maksimov, et al. 2012). 
Although small amounts of caulosegnin I and II were detected after cultivation of the native 
hosts, the production levels were too low for isolation. Heterologous expression of these gene 
clusters was optimized in an E. coli host to produce large enough quantities of each natural 
product for isolation and structure elucidation (Hegemann, Zimmermann, Xie, et al. 2013). A 
follow-up study combined genome mining with this optimized strain of E. coli to identify a 
further 10 lasso peptides from sequenced Proteobacteria (Hegemann, Zimmermann, Zhu, et al. 
2013). This method can be used for not only genetically intractable hosts, but also to distinguish 
between products in hosts that produce a variety.   
1.5.2 Chemoselective enrichment, genomisotopic labeling, and selective enzymatic 
derivatization 
Detection of lower-abundance metabolites is often hindered by the overwhelming signal 
of abundant natural products. Therefore, Erin Carlson and coworkers devised a strategy to enrich 
for a specific subset of natural products from a biological systems. Therein, derivatized-resin 
chemical probes, designed to target specific functional groups or post-translational modifications, 
were used for the chemoenrichment of specific natural products. This method was initially used 
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for the identification of biomarkers and therapeutic targets (Carlson, et al. 2007). Recently, the 
technology has been used to enrich for specific natural products within crude bacterial extract 
(Figure 1.3 B) (Odendaal, et al. 2011). When combined with genome-guided bacterial 
prioritization, this becomes a robust natural product discovery approach. 
The genomisotopic approach combines genome mining of natural product gene clusters 
with isotope-guided fractionation to isolate novel natural products. This method was used for the 
isolation of the nonribosomal peptide (NRP) orfamide A. The researchers first identified a gene 
cluster expected to produce a novel NRP. An isotope-labeled amino acid that was predicted to 
exclusively be incorporated into the unknown compound was then selected, and incorporation 
was detected using NMR (an isotope-sensitive technique) to guide identification and isolation 
(Gross, et al. 2007). These labeling tools represent a good alternative to heterologous expression 
for clusters that are too large or difficult to express in a heterologous host.  
To that same end, an enzymatic approach was created to rapidly enrich phosphonate 
natural products from the spent medium of bacteria (Gao, et al. 2014). Phosphonate natural 
products have high polarity and water solubility, making them relatively difficult to purify. The 
phosphonate O-methyltransfease DhpI, from the dihydrophos biosynthetic pathway, was found to 
non-specifically methylate other phosphonate natural products (Lee, et al. 2010). Gao et al. 
accordingly used DhpI to develop a method to label novel phosphonates in bacterial spent 
medium with either a CH3 or CD3 group. This altered stable isotope composition is detectable 
using mass spectrometry. This method was used to identify and purify novel phosphonate 
biosynthetic intermediates from the strain Streptomyces sp. WM6372 (Gao, et al. 2014). 
1.5.3 Mass spectrometry guided isolation 
 Mass spectrometry (MS) has traditionally been an essential technique for the 
identification and structural elucidation of many natural products. However, recently, a MS 
method was created particularly to correlate biosynthetic gene clusters to natural products 
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(Kersten, et al. 2011). Initial MS data was obtained from a bacterial organism of interest. Putative 
natural products from the initial MS were then subjected to tandem MS and analyzed for a 
“sequence tag”. The sequence tag—generated from the mass shift sequence in the tandem MS—
represents a subset of amino acids that are in the natural product and can subsequently be used as 
a genome-mining query for the identification of the gene cluster (Figure 1.3 C). This method can 
be used to identify both ribosomal and non-ribosomal natural products, provided they are 
peptidic. Furthermore, common post-translational modifications were taken into account for the 
generation of the sequence database, expanding the method’s utility for identifying natural 
products from uncharacterized gene clusters. The tag-based search strategy was used for the 
identification of nine novel natural products and their associated gene clusters (Kersten, et al. 
2011). 
 This technique was expanded with the introduction of tandem MS networking (Nguyen, 
et al. 2013). MS/MS networking was used to relate all detectable metabolites according to their 
fragmentation spectra—which in turn depend on each metabolite’s molecular structure. The MS-
based genome mining from the previous study was then used to correlate the MS network clusters 
with gene clusters (Figure 1.3 C). This method was shown to be capable of identifying natural 
products from unsequenced organisms by utilizing the MS network to identify similar natural 
products from a sequenced organism. This natural product production data can be extrapolated 
quickly to new samples solely based on MS signatures without the effort in genome sequencing 
(Nguyen, et al. 2013).  
1.5.4 Reactivity-based screening 
Reactivity-based screening (RBS) utilizes the intrinsic chemical reactivity of natural 
products to create probes that allow for the easy MS detection of natural products. RBS relies on 
the predictable presence of functional groups with known, selective reactivity, such as dehydrated 
amino acids (Cox, et al. 2014). 
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The dehydrated amino acids (DHAAs) dehydroalanine and dehydrobutyrine are 
frequently found in natural products, in particular the thiopeptide subclass of TOMMs. As 
mentioned previously, almost every identified thiopeptide gene cluster contains a lanthipeptide-
like dehydratase that eliminates water from Ser and Thr residues to give α,β-unsaturated amino 
acids. These dehydratases have previously been used in conjunction with CD fusion proteins and 
the ‘hetero-Diels-Alderase’ to identify thiopeptide gene clusters (Li, Qu, et al. 2012). 
It has been demonstrated that thiol nucleophiles participate in nucleophilic 1,4-addition to 
α,β-unsaturated carbonyl/imine DHAAs under mild conditions to yield covalent thioether 
adducts. Thus, it was envisioned this well-established, reliable chemistry could be used as a 
chemical handle for the discovery of DHAA-containing natural products. First, bioinformatically 
identified bacteria containing a lanthipeptide-like dehydratase are grown, and the natural products 
are extracted with an organic solvent. A portion of this extract then undergoes treatment with 
dithiothreitol (DTT) in the presence of base. DTT was chosen as the thiol probe owing to its low 
cost and ubiquity in many chemical laboratories. If reactive DHAA moieties are present in the 
cell-surface extract, the resulting DTT adducts increase the mass of the exported metabolite by 
multiples of 154.0 Da. Differential mass spectrometry between the unreacted control and the 
DTT-reacted extracts readily identifies the compounds containing DHAAs within a 
predetermined mass range. This reactivity-based screening method, when combined with 
bioinformatic analysis of biosynthetic gene clusters to prioritize strains, can be used to quickly 
identify, isolate, dereplicate and characterize natural products (Cox, et al. 2014, Li, Girard, et al. 
2012).  
1.6 Summary and Outlook 
TOMMs are a large class of peptidic natural products that are post-translationally 
modified to install heterocycles. Some TOMMs have been extensively characterized, including 
SLS and MccB17, however the majority of TOMMs are unknown natural products which 
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represent an untapped reservoir of potentially therapeutically useful compounds. Given the 
remarkable structural and functional diversity of characterized TOMMs, a basic understanding of 
the synthetic capability of microbes to produce TOMMs is desirable. TOMMs are produced 
ribosomally, making them easily identified using bioinformatics by identification of the 
modification enzymes. In Chapter 2, we use genome mining to characterize the diversity of 
TOMM biosynthetic gene clusters. We identify 20 families of TOMMs, 9 of which had never 
been characterized. In Chapter 2, we also discuss the phylogenetic diversity of the identified 
TOMM clusters along with the precursor peptide and modification enzyme diversity.  
 Traditional natural product discovery often identifies compounds using activity based 
screening. Because of rediscovery, without a strain prioritization step this method becomes 
burdensome, forcing scientists to screen thousands (or millions) of strains to find novel 
compounds. Furthermore, many compounds are missed because they lack the single, specific 
activity that is used in the screen. With the advent of sequencing it became apparent that many 
compounds were not being identified using this activity screening technique. In Chapter 3, we 
identify a TOMM biosynthetic gene cluster from Sulfolobus acidocaldarius and use this gene 
cluster to attempt to characterize the natural product. This is one of the few TOMM gene clusters 
identified in an Archaeal species and interestingly, similar clusters were also identified in 
bacterial producers. Although the natural product remains elusive, we outline some preliminary 
characterizations of this cluster and similar bacterial clusters. 
Genome mining has become an extremely useful tool to identify novel biosynthetic gene 
clusters, and here we identify nine novel families of TOMMs. However, as suggested in Chapter 
3, identification of novel compounds produced from these gene clusters of interest is much more 
difficult than identifying the gene clusters themselves. Therefore, new, rapid methods to correlate 
compounds with biosynthetic gene clusters are desired. In Chapter 4, we discuss a novel method 
for the identification of compounds containing DHAAs. Our strategy uses a commercially 
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available thiol, DTT, for the covalent labeling of activated alkenes by nucleophilic 1,4-addition. 
Modification is easily discerned by comparing MS of reacted and unreacted cell surface extracts. 
We combined this reactivity-based screening method with the bioinformatics analysis of TOMMs 
to prioritize strains capable of producing natural products with DHAAs. We anticipate, with the 
rise in sequencing data, that this method, along with other chemoselective reactions, will provide 
a powerful tool to correlate natural products with biosynthetic gene clusters.  
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1.7 Figures 
 
 
Figure 1.1 | Overview of a TOMM gene cluster and biosynthesis. (A) Example of a TOMM 
biosynthetic gene cluster. (B) The precursor peptide (black) is modified by the cyclodehydratase 
(C and D proteins, green and blue) to install heterocycles. Heterocycles can be further oxidized 
with the dehydrogenase (B protein, yellow). Additionally, further modifications can be installed 
onto the precursor peptide by ancillary modification enzymes. A protease (orange) then cleaves off 
the leader peptide (or follower). Further modifications can occur after leader peptide cleavage (not 
depicted).  
  
16 
 
 
Figure 1.2 | Representative TOMM natural products. Examples of structures of TOMMs from 
different classes are depicted.  
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Figure 1.3 | Methods for correlating biosynthetic gene clusters to natural products. (A) Gene 
deletion profiling uses a gene deletion from either the natural host or a heterologous host (depicted 
as blue gene). Comparative metabolic profiling (using mass spectrometry or liquid 
chromatography) is used to identify missing peaks from the deletion strain (red peak). (B) 
chemoseletive enrichment uses a capture agent to capture natural products from bacterial extracts. 
Once enriched, the natural products can be released and further characterization can be performed. 
(C) Mass spectrometry can be used to identify a sequence tag to relate back to natural product gene 
clusters (left) or natural product cluster can be used to identify similar natural products from similar 
species (right). (D) Reactivity-based screening utilizes a specific probe to label particular functional 
groups (diamond, star, triangle labeled with circles). Comparative mass spectrometry can then be 
utilized to identify natural products labeled with the probe.  
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CHAPTER II: THE GENOMIC LANDSCAPE OF RIBOSOMAL PEPTIDES 
CONTAINING THIAZOLE AND OXAZOLE HETEROCYCLES 
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Abstract 
Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a 
burgeoning class of natural products with diverse activity that share a similar origin and common 
features in their biosynthetic pathways. The precursor peptides of these natural products are 
ribosomally produced, upon which a combination of modification enzymes installs diverse 
functional groups. This genetically encoded peptide-based strategy allows for rapid 
diversification of these natural products by mutation in the precursor genes merged with unique 
combinations of modification enzymes. Thiazole/oxazole-modified microcins (TOMMs) are a 
class of RiPPs defined by the presence of heterocycles derived from cysteine, serine, and 
threonine residues in the precursor peptide. TOMMs encompass a number of different families, 
including but not limited to the linear azol(in)e-containing peptides (e.g. streptolysin S, microcin 
B17, and plantazolicin), cyanobactins, thiopeptides, and bottromycins. Although many TOMMs 
have been explored, the increased availability of genome sequences has illuminated several 
unexplored TOMM producers. Given the remarkable structural and functional diversity displayed 
by known TOMMs, a comprehensive bioinformatic study to catalog and classify the entire RiPP 
class was undertaken. Here we report the characterization of nearly 1,500 TOMM gene clusters 
from genomes in the The European Molecular Biology Laboratory (EMBL) and The European 
Bioinformatics Institute (EBI) sequence repository. Genome mining suggests a complex 
diversification of modification enzymes and precursor peptides to create more than 20 distinct 
families of TOMMs, nine of which have not heretofore been described. Many of the identified 
TOMM families have an abundance of diverse precursor peptide sequences as well as unfamiliar 
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combinations of modification enzymes, signifying a potential wealth of novel natural products on 
known and unknown biosynthetic scaffolds. Phylogenetic analysis suggests a widespread 
distribution of TOMMs across multiple phyla; however, producers of similar TOMMs are 
generally found in the same phylum with few exceptions. The comprehensive genome mining 
study described herein has uncovered a myriad of unique TOMM biosynthetic clusters and 
provides an atlas to guide future discovery efforts. These biosynthetic gene clusters are predicted 
to produce diverse final products, and the identification of additional combinations of 
modification enzymes could expand the potential of combinatorial natural product biosynthesis.  
2.1 Introduction 
Recently, genome mining has revealed the tremendous sequence diversity of a 
pharmaceutically relevant family of natural products, the ribosomally synthesized and post-
translationally modified peptides (RiPPs) (Haft, et al. 2010, Lee, et al. 2008, Leikoski, et al. 
2013, Letzel, et al. 2014, Maksimov, et al. 2014, Mohimani, et al. 2014, Velasquez, et al. 2011). 
The gene clusters for these natural products have been discovered in all three domains of life, and 
their structural diversity continues to expand as more knowledge accumulates regarding these 
natural products and their biosynthesis. RiPPs populate a diverse chemical and genetic landscape, 
including, but not limited to, lanthipeptides, thiazole/oxazole-modified microcins (TOMMs), 
lasso peptides, and linaridins (Arnison, et al. 2013). The ribosomal origin of the starting material 
unites this otherwise disparate group of natural products. While the genes for most precursor 
peptides are located near to those for the modification enzymes within the genome, there are 
examples of precursors located elsewhere (e.g. heterocycloanthracins (Haft 2009) and 
prochlorosins (Li, Sher, et al. 2010, Zhang, et al. 2014)). With few exceptions, the C-terminal 
portion of the precursor peptide (often referred to as the core region) is post-translationally 
modified while the N-terminal portion (leader region) harbors binding motifs that recruit the 
modification enzymes. Common core modifications include heterocycles, dehydrated amino 
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acids, methylations, acetylations, backbone crosslinks, and many others (Arnison, et al. 2013, 
Dunbar, et al. 2013, McIntosh, et al. 2010). A number of these modifications restrict the 
conformational flexibility of the peptide, which plays a part in endowing the final product with a 
specific activity. Following the enzymatic processing of the core, the unmodified leader region is 
typically removed by a protease, resulting in either the fully mature product or a substrate for 
further modifications (Figure 2.1A) (Oman, et al. 2010). Certain RiPPs swap the functions of the 
N- and C-terminal regions (e.g. bottromycins (Crone, et al. 2012, Gomez-Escribano, et al. 2012, 
Hou, et al. 2012, Huo, et al. 2012)), while others have co-opted macrocyclization enzymes to 
excise the leader peptide (e.g. cyanobactins (Agarwal, et al. 2012, Koehnke, et al. 2012) and 
thiopeptides (Bowers, et al. 2010, Malcolmson, et al. 2013, Tocchetti, et al. 2013)). Regardless, 
the RiPP biosynthetic strategy is capable of producing structurally diverse compounds with 
minimal genetic space because the ribosome is utilized to synthesize the majority of the natural 
product scaffold. Furthermore, natural product variation can be expanded with the simple 
mutation of the core peptide, or addition and deletion of modification enzymes, leading to a 
variety of structures and bioactivities within the class. The particular combinations of precursor 
sequence and modification enzymes ultimately define the classes of RiPPs, and bioinformatics 
can readily identify and classify RiPP gene clusters using homology to these common enzymes 
(Velasquez, et al. 2011). 
 TOMMs are a large subclass of RiPPs encompassing a wide array of structures and 
bioactivities that are defined by the presence of azole and azoline heterocycles derived from Cys, 
Ser, Thr residues in the precursor peptide (Lee 2008, Melby, et al. 2011). Examples of studied 
TOMMs include microcin B17 (DNA gyrase inhibitor) (Li, et al. 1996), , streptolysin S 
(cytolysin) (Mitchell 2009), plantazolicin (antibacterial) (Molohon, et al. 2011, Scholz, et al. 
2011), cyanobactins (anticancer, antimalarial, and others) (Schmidt, et al. 2005), and the 
thiopeptides (translation inhibitors) (Kelly, et al. 2009, Liao, et al. 2009, Morris, et al. 2009) 
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(Figure 2.2). The hallmark of a TOMM gene cluster is the presence of a cyclodehydratase that 
installs azoline heterocycles onto a precursor peptide (Dunbar, et al. 2012, Dunbar, et al. 2013, 
Li, et al. 1996, Melby, et al. 2012). In some cases, a locally-encoded dehydrogenase then oxidizes 
the azoline to the corresponding azole heterocycle (Belshaw, et al. 1998, Melby, et al. 2014, 
Milne, et al. 1999). TOMM biosynthetic clusters regularly encode ancillary modification 
enzymes that increase structural complexity.  
 Given the structural and functional diversity of previously explored TOMMs, a 
fundamental understanding of the synthetic capabilities of bacteria and archaea to produce these 
natural products is desirable. Here we have analyzed sequences from The European Molecular 
Biology Laboratory (EMBL) and The European Bioinformatics Institute (EBI) sequence database 
to view the distribution, evolution and structural potential of TOMMs. Nearly 1,500 biosynthetic 
gene clusters were identified, many of which appear to encode novel natural products. 
Additionally, some gene clusters contain heretofore-undescribed combinations of ancillary 
modification enzymes, potentially expanding the chemical complexity of TOMMs. Furthermore, 
precursor peptides from both characterized and uncharacterized families were analyzed to 
identify common motifs. This study defines the genomic landscape of TOMM natural products.  
2.2 Genome Mining and Isofunctional Grouping 
TOMM biosynthetic gene clusters are defined by the presence of the aforenmentioned 
cyclodehydratase, which is composed of an E1 ubiquitin-activating enzyme homolog (C protein) 
and a member of the YcaO superfamily (D protein). In roughly half of all TOMM clusters, the 
genes encoding the C and D proteins are fused and expressed as a single polypeptide (CD fusion). 
This fusion underscores the important collaboration of the C and D proteins in cyclodehydratase 
function. Recently, it was demonstrated that the D protein formally catalyzes the 
cyclodehydration reaction, while the C protein engages the leader peptide and potentiates the 
cyclodehydration reaction by several orders of magnitude (Dunbar, et al. 2014, Dunbar, et al. 
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2012, Mitchell 2009). In at least two cases (e.g. bottromycin and trifolitoxin), the D protein is 
believed to act in the absence of a C protein (Breil, et al. 1996, Crone, et al. 2012, Gomez-
Escribano, et al. 2012, Hou, et al. 2012, Huo, et al. 2012). In a sizeable percentage of TOMM 
gene clusters, a flavin mononucleotide (FMN)-dependent dehydrogenase (B protein) is encoded, 
which has been shown to oxidize select azoline rings to azoles (Li, et al. 1996, Melby, et al. 2014, 
Milne, et al. 1999).  
In an attempt to catalog all TOMM biosynthetic gene clusters, the local genomic regions 
of YcaO homologs within UniProtKB were characterized (Figure 2.1B). YcaO homologs were 
chosen as the focus of this search primarily because it has been demonstrated that the B and C 
proteins can be omitted in TOMM production, whereas D proteins (YcaO homologs) are always 
present (e.g. bottromycin). Furthermore, the YcaO domain has considerably fewer non-TOMM 
related homologs than the B and C proteins (i.e. bona fide E1-family enzymes like ThiF and 
MoeB for the C protein and other FMN-dependendent dehydrogenases), therefore producing 
fewer false positives. Notwithstanding, a subset of YcaO homologs are known to be present in 
non-TOMM related settings (previously referred to as “non-TOMM YcaO” and “TfuA-associated 
YcaO”) (Dunbar, et al. 2014), and therefore, multiple methods have been used to distinguish 
TOMM-producing gene clusters from non-producers. Using the genomic region surrounding 
ycaO genes (10 kb on either side), a combination of BLAST score and synteny was used to 
classify biosynthetic gene clusters into families (Figure 2.1B – Step 1 and 1C). Potential TOMM 
gene clusters were first analyzed for the presence of a C protein or CD fusion protein within the 
flanking genomic region (10 kb on either side of the ycaO gene). The gene cluster was also 
analyzed for the presence of a precursor peptide. Often, precursors evade automated gene finders 
due to their short lengths; therefore, intergenic regions were also analyzed for potentially 
unannotated precursor peptide genes. Precursor peptides were annotated under the assumption 
that they are short open reading frames (<150 amino acids) and typically contain an abundance of 
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Gly, Cys, Ser, and Thr residues in the core region. This approach does not locate precursor 
peptides that are not in close proximity to the D proteins (>10 kb away) or those with a low 
proportion of heterocyclizable residues. Of the potential TOMM clusters identified in the present 
study, 46% contained an identifiable precursor peptide gene within 10 kb of the D protein. As the 
bottromycins do not contain a C protein homolog (i.e. stand-alone D proteins) and do not have 
Gly-Cys-Ser-Thr rich precursor peptides, a manual analysis was performed to identify 
bottromycin-like gene clusters. If a TOMM cluster was identified using this criteria, all gene 
clusters in a family were annotated as TOMMs, regardless of whether the other clusters contained 
an identifiable C protein or precursor peptide. This cataloging procedure identified nearly 1,500 
putative TOMM biosynthetic gene clusters in the prokaryotic genomes available from EMBL 
(Figure 2.1). This is likely an underestimate because (i) very little is known about stand-alone 
TOMM clusters (lacking C protein) (ii) it is unknown whether TfuA-associated YcaO proteins 
can adorn peptides with azoline and azole heterocycles and (iii) highly unusual precursor peptides 
would not be detected by the strategy employed. Furthermore, RefSeq (NCBI) records are not 
systematically included in UniProtKB, thus many TOMM proteins from RefSeq were not 
included in this identification process. 
To visualize the relationship landscape of TOMM families, a sequence similarity network 
was produced using the D proteins from each gene cluster (Figure 2.3 and 2.4) Characterized 
gene cluster families, identified by similarity to previously explored TOMM clusters, were then 
mapped onto the network. D proteins from similar TOMM families were more similar to each 
other, irrespective of the phyla from which the gene clusters originated. This suggests, similar to 
other natural products like lanthipeptides (Yu, Zhang, et al. 2013, Zhang, et al. 2012) and 
phosphonates (Ju, et al. 2014, Yu, Doroghazi, et al. 2013), that the structure and function of a 
particular TOMM can be predicted not only by the sequence of the precursor peptide, but also by 
the similarity of the modification enzymes. Therefore, it is not necessary in all cases to identify 
31 
 
the putative precursor peptide to predict the family of the TOMM natural product. Examining 
isofunctional clusters in multiple genomic backgrounds also allows inference of gene cluster 
boundaries and the encoded enzymes that are involved in biosynthesis (Doroghazi, et al. 2013). 
Using a BLAST expectation value of E-54, there are 11 anticipated isofunctional groups that 
contain at least one previously explored TOMM. The groups have been designated as follows: 
cytolysin, cyanobactin, thiopeptide, microcin B17 (MccB17), NHLP/Nif11, goadsporin, 
heterocycloanthracin (HCA), hakacin, plantazolicin (PZN), YM-216319, and bottromycin (Figure 
2.3).  
As illustrated on the sequence similarity network, the families for nearly 60% of 
predicted TOMMs can be inferred from their similarity to a characterized D protein. However, a 
considerable number of presumed isofunctional groups contain no characterized TOMMs, leaving 
a vast area of the natural product space yet to be characterized (Figure 2.3 and 2.5). There are 10 
presumed isofunctional groups with no explored TOMM clusters, which we have designated as 
the following: haloazolisin, faecalisin, helicobactin, mobilisin, propionisin, coryneazolisin type 1 
and type 2, thermoacidophisin, anabaenasin, and gallolytisin (Figure 2.4 and 2.6). These TOMM 
biosynthetic gene clusters encode a variety of unique peptides rich in Gly, Ser, Thr, and Cys, 
suggesting that they are the TOMM precursor peptide. Although defined by the installation of 
azoline heterocycles, the majority of TOMM gene clusters contain additional post-translational 
modification enzymes (Figure 2.7) as well as a plethora of novel precursor peptides (Figure 2.8). 
To analyze enzymatic commonalities between TOMM families, the proteins encoded in the 
genomic region surrounding the D proteins were clustered by similarity (Figure 2.9, 2.10, 2.11 ). 
These family-specific modification enzymes are described further within each TOMM family 
discussed below. 
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2.3 Isofunctional Groups with Explored TOMMs 
2.3.1 Microcin B17 
Microcin B17 (MccB17) is a quintessential example of a TOMM cluster containing a 
discrete cyclodehydratase (i.e. separate C and D proteins). The enzymes encoded by this cluster 
extensively modify the MccB17 core peptide to yield a DNA gyrase inhibitor (Li, et al. 1996, 
Yorgey, et al. 1994). The current analysis identified 30 gene clusters from Escherichia coli, 
Pseudomonas syringae, Pseudomonas putida, and Pseudomonas fluorescens, all of which have 
been previously identified as MccB17 producers (Lee, et al. 2008, Metelev, et al. 2013). The 
gene clusters from E. coli and Pseudomonas sp. are similar to the previously characterized 
clusters, and all contain homologs to the C protein (Figure 2.9: group 41), D protein (Figure 2.9: 
group 54), and three ATP-binding cassette (ABC)-like transporters (Figure 2.9: groups 2, 66, 67). 
The 19 identified MccB17 precursor peptides in E. coli clusters are identical in the core region 
and bear only a single substitution in the leader peptide; however, these peptides vary in the 
length of the glycine linker region at the N-terminus of the core. The nine precursors from 
Pseudomonas are considerably more divergent, only sharing the glycine-rich cyclized region with 
the E. coli precursors (Figure 2.8).  
2.3.2 Cytolysin 
Streptolysin S (SLS) is a potent cytolysin responsible for the characteristic β-hemolytic 
phenotype exhibited by Streptococcus pyogenes (Molloy, et al. 2011). The cytolysin family 
continues to grow, with over 300 clusters identified since the pioneering identification of the SLS 
gene cluster (Betschel, et al. 1998, Nizet, et al. 2000). Homologous clusters have been identified 
in other pathogenic bacteria including Listeria monocytogenes, Clostridium botulinum, 
Staphylococcus aureus, and Brachyspira murdochii (Letzel, et al. 2014, Molloy, et al. 2011). Of 
particular interest are the clusters identified in Spirochaetes and Lactobacillus crispatus because 
the Spirochaetes are not known to produce any toxins and Lactobacillus crispatus is a commensal 
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bacteria and therefore it is unknown why they both have the genetic capacity to produce SLS-like 
compounds (Molloy et al., submitted). Although the cytolysins form a single isofunctional group, 
the precursor peptides differ based on species. All of the identified clusters contain a discrete 
cyclodehydratase, a dehydrogenase, ABC transporters, and a CaaX-like protease (Maxson, et al. 
2015, Pei, et al. 2011) (Figure 2.7). Of the 312 identified clusters, 294 had identifiable precursor 
peptides. Six cytolysin TOMM clusters encode two precursor peptides, in line with a previous 
finding (Tabata, et al. 2013). All of the identified cytolysin precursor peptide cores contain a Gly 
residue followed by 10 or more potentially heterocyclized residues, suggesting that contiguous 
heterocyclization may be important for activity. The C-terminal regions of the core peptides 
(following the conserved, contiguous, heterocyclizable region) vary by species or are missing 
entirely (Spirochaetes). The core regions, including the variable C-termini, and the leader peptide 
of the precursor peptides from Streptococcus and Clostridium are more similar to each other than 
they are to the peptides from Staphylococcus and Listeria, which themselves share similarity. 
This is consistent with previous studies that showed that the Streptococcus enzymes could modify 
the Clostridium precursor peptide, but not the native Listeria precursor (Lee, et al. 2008, 
Mitchell, et al. 2009). Furthermore, the core region of the precursor peptide from Borrelia is 
more similar to that from Streptococcus than it is to that from Listeria, solidifying the previous 
findings that these peptides can be modified by the Streptococcus enzymes (Molloy et al., 
submitted). The C proteins involved in cytolysin biosynthesis are split by organism into two 
different enzyme groups (Figure 2.9), further corroborating the ability of only certain 
cyclodehydratases to modify precursor peptides in this family. The Streptococcus, Borrelia, 
Brachyspira, and Clostridium C proteins cluster together (Group 22), and the Listeria and 
Staphylococcus C proteins form a different cluster (Group 37). 
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2.3.3 Cyanobactin 
The cyanobactins represent one of the largest families of TOMMs with fused 
cyclodehydratases TOMMs. Cyanobactins are cyclic peptides produced by Cyanobacteria and 
are best known for their anticancer, antiviral and antimalarial effects (Namikoshi, et al. 1996, 
Nunnery, et al. 2010). This exercise only included cyanobactin biosynthetic gene clusters that 
were bioinformatically identified as TOMM gene clusters from UniProtKB sequences (there are 
known cyanobactins which lack azole/azoline heterocycles and the requisite D protein is missing 
from the cluster) (Sivonen, et al. 2010). The 56 cyanobactin clusters identified here often encode 
precursor peptides with hypervariable core regions. These diverse natural product template 
sequences are flanked by highly conserved cleavage sites that ultimately direct the excision and 
macrocylization of the mature cyanobactin from the precursor peptide (Agarwal, et al. 2012, 
Koehnke, et al. 2012, Lee, et al. 2009). In most clusters, a PatA-like protease recognizes and 
cleaves the N-terminal site. Then, a PatG-like protease recognizes the C-terminal site and 
catalyzes the N-to-C macrocyclization (Agarwal, et al. 2012, Houssen, et al. 2010, Koehnke, et 
al. 2012). In nearly one-third of the identified TOMM cyanobactins identified (18 total), PatG 
homologs are fused as a single polypeptide to FMN-dependent dehydrogenases for the oxidation 
of azoline heterocycles to the corresponding azoles (Figure 2.7). The identified PatA and PatG 
homologs form a group with other B proteins (lacking the protease) from similar clusters such as 
goadsporin and NHLP/Nif11 (Figure 2.9, group 9, also see section 2.3.4).  This enzyme group 
also contains homologs of the prenyltranferases in the cyanobactin gene clusters because there are 
homologous methyltransferase domains that are fused to either a PatA or the prenyltransferase 
domain, thus combining the group by similarity. Of the 56 total TOMM cyanobactin gene 
clusters, prenyltransferases were identified in 18 and these enzymes are expected to prenylate Ser, 
Tyr, and Thr residues within the precursor peptide core regions (Bent, et al. 2013, McIntosh, et 
al. 2011). Although cyanobactin gene clusters often encode multiple precursor peptides, they are 
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relatively long (~100 amino acids) and have a reduced richness of Cys, Ser, Thr (~20-30% in 
predicted core peptides) compared to other TOMM precursor peptides. Therefore, few 
cyanobactin precursor peptides were identified with the parameters used in this study. However, 
identification of many cyanobactin precursor peptides has been previously reported (Donia, et al. 
2008, Donia, et al. 2011, Schmidt, et al. 2009, Sivonen, et al. 2010).  
2.3.4 Nitrile hydratase-related leader peptides and Nif11-related precursor peptides  
Cyanobactin D proteins group with those for two other families of TOMMs, the nitrile 
hydratase-related leader peptides (NHLPs or NHLP-Burk, for clusters produced by Burkholderia 
species) and the Nif11-related precursor peptides (Figure 2.3 and 2.5) (Haft, et al. 2010). Unlike 
the cyanobactins, however, the NHLP and Nif11 families do not contain PatA/G-like proteases 
(Figure 2.7). 
NHLP precursors share sequence similarity to the alpha subunit of nitrile hydratases but 
are missing the catalytic requisite CxxCSC motif (Haft, et al. 2010). Nif11-derived peptides are 
only found in bacteria capable of fixing nitrogen and have similarity to the Nif11 protein, whose 
function is unknown. In some clusters, NHLP and Nif11 peptides are found concurrently. Similar 
to cyanobactins, both of these families of precursors again have hypervariable core regions, and 
some NHLP-Burk peptides appear to have multiple cleavage sites, suggesting the production of 
two compounds from a single precursor peptide (Haft, et al. 2010). The NHLP-Burk clusters 
contain tandem precursor peptide genes. In some NHLP-burk gene clusters, these precursors are 
fused, suggesting they may form a two-peptide product. Similar to cyanobactin precursor 
peptides, the NHLP, NHLP-Burk and Nif11 precursor peptides are long, making the proportion of 
Cys, Thr, and Ser within the predicted core peptide low. Therefore, these peptides were not 
identified using the parameters from this bioinformatics study (Haft, et al. 2010).  
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2.3.5 Goadsporin 
 Only two biosynthetic gene clusters for goadsporin production were identified in this 
study. Goadsporin promotes secondary metabolism and morphogenesis in actinomycetes at low 
concentration, but inhibits bacterial growth at higher concentrations (Onaka, et al. 2005). In 
addition to a fused TOMM cyclodehydratase and B protein, the goadsporin biosynthetic gene 
cluster contains a dehydratase for the conversion of Ser and Thr to dehydroalanine (Dha) and 
dehydrobutyrine (Dhb), respectively. These lanthipeptide-like dehydratase proteins are split into 
separate proteins (glutamylation and elimination domains, respectively) rather than a single 
polypeptide with two-domains that is often found in lanthipeptide gene clusters (Li and Kelly 
2010, Mavaro, et al. 2011, Ortega, et al. 2014, Yu, Zhang, et al. 2013, Zhang, et al. 2012). These 
two proteins form distinct enzyme groups containing the dehydratases from not only goadsporin, 
but also thiopeptide and coryneazolisin producers (discussed below, Groups 8 and 15).  
2.3.6 Thiopeptides 
 Thiopeptides are highly modified macrocylic TOMMs best known for their inhibition of 
protein synthesis by interacting with the 50S ribosomal subunit or elongation factor Tu (Bagley, 
et al. 2005). The D proteins involved in thiopeptide biosynthesis do not form a single 
isofunctional group at e-value E-54 like the D proteins from most other TOMM clusters. Instead, 
roughly half form a unique group while the other half clusters with the HCA producers (Figure 
2.3) (Haft 2009). After further investigation, it became apparent that there exists two different 
families of thiopeptide biosynthetic gene clusters. One family has a single fused cyclodehydratase 
that clusters with the heterocycloanthracin (HCA) producers, while the other class encodes a 
discrete C and D cyclodehydratase; occasionally, this type also contains an additional fused 
cyclodehydratase.  
Thiopeptide gene clusters that group with HCA gene clusters at E-54 include those 
responsible for production of thiostrepton, thiocillin, and other well-characterized thiopeptides. 
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Within these clusters, 85% contain a ThiF-like domain containing protein (TOMM F protein, 
Figures 2.7 and 2.9) that is presumably responsible for precursor peptide binding, as has been 
demonstrated during HCA biosynthesis (vide infra, Dunbar et al., submitted). Only two natural 
products have been identified from the thiopeptide gene clusters that contain the discrete 
cyclodehydratase, TP-1161(Engelhardt, Degnes, Kemmler, et al. 2010, Engelhardt, Degnes and 
Zotchev 2010) and berninamycin(Malcolmson, et al. 2013). Only 25% of these gene clusters 
contain an F protein, suggesting that the C proteins from these gene clusters are capable of 
engaging the precursor peptide on their own.  
The distinguishing feature of thiopeptides is a central nitrogen-containing six-membered 
ring formed from two dehydroalanines (Bowers, et al. 2010, Malcolmson, et al. 2013, Tocchetti, 
et al. 2013). The [4+2] cycloaddition enzyme responsible for the formation of the thiocillin 
macrocycle was recently heterologously produced and studied (Wever, et al. 2015). Homologs to 
this protein are ubiquitous in thiopeptide gene clusters (Bowers, et al. 2010).  
2.3.7 Plantazolicin 
Plantazolicin (PZN), a recently characterized natural product with highly discriminating 
antibiotic activity, forms a small isofunctional group in the sequence similarity network with 13 
members (Figure 2.3) (Molohon, et al. 2011, Scholz, et al. 2011). The PZN gene cluster was 
initially identified in Bacillus amyloliquefaciens, but has since been identified in additional 
Bacillus species as well as from actinomycetes such as Clavibacter, Brevibacterium, and 
Corynebacterium (Molohon, et al. 2011). The current study identifies additional PZN clusters in 
the Nesterenkonia and Sorangium genera. In an early report on PZN (Scholz, et al. 2011), it was 
determined that dimethylation of the N-terminal arginine was required for activity. The PZN S-
adenosyl methionine (SAM)-dependent methyltransferase responsible for this dimethylation was 
later reconstituted and found to be specific for PZN-like substrates, appearing to require an N-
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terminal arginine followed by a thiazole (Hao, et al. 2015, Lee, et al. 2013, Piwowarska, et al. 
2013). Due to this specificity, it is not surprising that the PZN methyltransferase forms a distinct 
enzyme group within the modification enzymes (Figure 2.9, group not shown). The precursor 
genes from these clusters are smaller (~130 bp) than most TOMM precursor peptides and 
consequently, all were identified manually. Of the identified clusters, 12 contain the PZN-specific 
methyltransferase (all but the Nesterenkonia cluster) and 10 have a core peptide region predicted 
to begin with Arg. The core regions of these 10 precursor peptides are very similar to the core of 
the initially-described PZN peptide from B. amyloliquefaciens, containing 5 heterocyclizable 
residues near the N-terminus, followed by two nonpolar amino acids, and 5 or 6 more 
heterocyclizable residues near the C-terminus (Figure 2.8).  
2.3.8 Hakacin 
The TOMMs of the hakacin group (Figure 2.3) have discrete cyclodehydratases, and 
although the C and D proteins have been extensively characterized in vitro, the final structure and 
function of any hakacin remains undetermined (Dunbar, et al. 2012, Dunbar, et al. 2013, Melby, 
et al. 2012, Melby, et al. 2014). The current analysis identified similar clusters from 16 Bacillus 
cereus and Bacillus thuringiensis strains. In addition to the cyclodehydratase, hakacin gene 
clusters encode a B protein, protease, ABC transporters, and a group-specific protein of unknown 
function (Figure 2.7). Interestingly, there are three groups of hakacin precursor peptides that vary 
in the core region; however, the leader regions are nearly identical (Figure 2.8).  
2.3.9 Heterocycloanthracin 
The heterocycloanthracin (HCA) producers comprise a large group of TOMMs with 254 
being identified in this study. First bioinformatically identified in 2009,(Haft 2009) the genes 
responsible for the production of HCA were recently reconstituted in vitro (Dunbar et al., 
submitted). These genes are widely distributed in the Bacillus cereus group, with the majority of 
the sequenced strains containing a HCA gene cluster. All HCA producers contain a fused 
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cyclodehydratase that that is missing ~100 amino acids from the N-terminal C protein domain. 
This truncation means that the cyclodehydratase lacks the critical residues involved in peptide 
recognition. It was recently demonstrated that the ThiF-like protein (TOMM F protein, 
IPR022291) identified in all HCA clusters (and most thiopeptides) is responsible for leader 
peptide binding. The TOMM F protein also forms a complex with the truncated 
cyclodehydratase, which is now dependent on the F protein for activity (Dunbar et al., submitted). 
F proteins have so far only been found in the gene clusters of HCA producers and the 
thiopeptides that group with them, and they form a single cohesive group within the modification 
enzymes (Figure 2.9, group 4). 
The clusters of the B. cereus HCA clusters contain additional modification enzymes, 
including a B protein, a SAM-dependent methyltransferase, a succinyltransferase, and a 2-
oxoglutarate dehydrogenase, suggesting additional modifications could decorate these natural 
products. However, the genomic regions of these clusters are almost identical between strains, 
making it difficult to assign gene cluster boundaries. After comparison of the entire HCA family, 
only the fused cyclodehydratase, F protein, and B protein are present within all clusters and are 
potentially the only necessary enzymes within this cluster (unless there are other essential 
enzymes elsewhere on the chromosome).   
Until 2009, an HCA precursor peptide could not be identified because in a majority of the 
B. cereus HCA clusters, the gene encoding the precursor peptide is not located in the local 
genomic context of the cyclodehydratase (Haft 2009). Using the method outlined above, any 
precursor peptides further than 10 kb from the D protein were not annotated, and therefore the 
majority of the precursor peptides from these clusters were left unannotated. However, 14 HCA 
precursor peptides were located close to the D proteins and thus were successfully annotated. 
These precursor peptides were similar to the ones identified in previous studies, and most 
contained either Cys-Ser or Gly-Cys repeats (Haft 2009).  
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2.3.10 Bottromycin and other TOMMs with a stand-alone D protein  
Bottromycins display potent antimicrobial activity against methicillin-resistant 
Staphylococcus aureus and vancomycin-resistant enterococci (Kobayashi, et al. 2010). 
Characterized bottromycin gene clusters each contain two genes with YcaO-like domains similar 
to the D protein component of the TOMM cyclodehydratase, but no recognizable C protein 
(Crone, et al. 2012, Gomez-Escribano, et al. 2012, Hou, et al. 2012, Huo, et al. 2012). One of the 
D proteins is suspected to convert Cys to thiazoline while the second is postulated to be 
responsible for the formation of the macroamidine. The absence of a C protein in these stand-
alone D protein TOMM clusters makes genome mining for TOMMs inherently more difficult. 
Bottromycin gene clusters contain methyltransferases necessary for the O-methylation of the 
aspartic acid and the methylation at non-nucleophilic β-carbons in bottromycin biosynthesis, 
respectively. For this study, similarity of these proteins as well as similarity of the D proteins 
were used to identify bottromycin and other stand-alone D protein clusters.  
There are two known groups of YcaO domain-containing proteins (homologs of D 
proteins, but not associated with a C protein), the “non-TOMM YcaOs” and the “TfuA-associated 
non-TOMM YcaOs”. The latter co-occurs in clusters with a gene encoding for the protein TfuA, 
which is implicated in trifolitoxin production (Breil, et al. 1996, Dunbar, et al. 2014). Although 
all of these YcaO proteins contain the canonical ATP-binding pocket, the substrate of the non-
TOMM and TfuA-associated YcaOs are unknown. These proteins were not included in this study; 
however, with the discovery of bottromycin biosynthesis, it is apparent that YcaO domain-
containing proteins have the potential to synthesize natural products without a canonical C 
protein. Many of these uncharacterized YcaO proteins have the potential to produce novel natural 
products. Further bioinformatic and biochemical analysis will be necessary to determine if the 
non-TOMM YcaO enzymes are indeed involved in natural product biosynthesis. 
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2.4 Presumed Isofunctional Groups with no Characterized Members 
 A significant number of TOMM natural product classes do not group with any 
characterized biosynthetic clusters, thus representing an untapped source of structure and 
functional novelty (Figures 2.3 and 2.4).  
2.4.1 Faecalisin 
The largest group of uncharacterized TOMMs, referred to here as faecalisins, is 
comprised of 124 gene clusters found predominantly in Enterococcus faecalis. These clusters 
have discrete cyclodehydratases, and the D protein from the cluster is most related to those of 
MccB17 and a few of the stand-alone clusters (Figures 2.5 and 2.6). However, the C protein, 
responsible for leader peptide binding, does not form a group with C proteins from other TOMM 
classes (Figure 2.9, group not shown), implying that these clusters differ significantly from the 
MccB17 clusters. The faecalisin gene clusters also contain ABC transporters along with two 
hypothetical proteins that could be responsible for further modifications, but have no similarity 
with other TOMM ancillary modification enzymes (Figure 2.7).  
Precursor peptide genes were identified for 102 of the faecalisin producers in this study, 
20 of which contained two precursor genes within its cluster. Each of the identified precursor 
peptides has a core region containing a Gly repeat linker followed by a Cys repeat region (Figure 
2.6), and all but three differ only by the length of the Gly linker, plus contain identical leader 
peptides (Figure 2.6). 
2.4.2 Propionisin 
A group of 19 TOMM gene clusters from Propionibacterium contain a discrete 
cyclodehydratase with the D protein most related to the cytolysin family (Figures 2.5, 2.6 and 
2.7) though the C protein does not form a group with the other C proteins (Figure 2.9, group not 
shown). These propionisin gene clusters contain ABC transporters as well as hypothetical 
proteins that do not share any similarity to other TOMM enzymes, but could potentially modify 
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the natural product (Figure 2.7). Unlike most TOMM clusters, the propionisin gene clusters also 
contain multiple CaaX-like proteases (Maxson, et al. 2015).  
A precursor peptide gene was identified for all predicted propionisin gene clusters. The 
majority of the strains (14/19) contained two identified precursor peptide genes, and three strains 
contained three. The precursor peptides cluster by similarity into three groups. The first two 
groups differ dramatically in leader peptide sequence but contain nearly identical core regions. 
These core regions appear similar to those of the cytolysin precursor peptides because they 
contain contiguous heterocyclizable residues followed by C-terminus with no Cys, Ser, and Thr. 
The third group of propionisin precursor peptides, meanwhile, have almost no similarity to the 
other two. Further experimentation is necessary to establish if these are actual TOMM precursor 
peptides (Figure 2.8).  
2.4.3 Helicobactin 
Another putative type of TOMM uncovered, the helicobactins, are encoded by 10 
Helicobacter pylori strains. These TOMM clusters contain a discrete cyclodehydratase with a D 
protein most closely related to those of the hakacins and thermoacidophisins (Figures 2.5 and 
2.6), while the C protein groups by itself when compared to other homologs (Figure 2.9, group 
83). These clusters also contain a B protein and a hypothetical protein that shares similarity only 
with other H. pylori enzymes. Some helicobactin clusters contain ABC transporters as well as a 
protease (Figure 2.7); however, this is not strictly conserved throughout the family. Precursor 
peptides were identified for eight of the helicobactin clusters. These precursor peptides are nearly 
identical, with only a single substitution in the predicted leader peptide. 
2.4.4 Mobilisin 
The mobilisins, a family of TOMMs produced mainly by strains of Mobiluncus, form a 
predicted isofunctional group with 52 D proteins (Figure 2.3). The D proteins from these clusters 
are most similar to those from the gallolytisin and haloazolisin clusters (Figure 2.5 and 2.6). The 
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mobilisin gene clusters appear to only have the B, C, and D proteins (Figure 2.7). Precursor 
peptides were not identified bioinformatically for these clusters, implying that these precursor 
peptides could either be extremely different from previously identified or be encoded elsewhere 
in the genome. Further manual analysis identified a short peptide near the fused 
cyclodehydratase, however the core region contains a low percentage of Cys, Ser, and Thr 
residues explaining the lack of automatic identification. 
2.4.5 Haloazolisin 
Halophilic archaea contain a family of nearly 100 TOMM gene clusters, which we term 
the haloazolisins. These gene clusters have very divergent fused cyclodehydratases with a barely 
recognizable C protein domain; however, some clusters do contain a recognizable precursor 
peptide, which allowed for their classification as TOMM gene clusters (Figure 2.8). This 
cyclodehydratase is most similar to those from other uncharacterized TOMM clusters, including 
the anabaenasin, mobilisin, and gallolytisin clusters (Figure 2.5 and 2.6). After further analysis, a 
precursor peptide was located near a F-like protein elsewhere on the chromosome of 
Haloterrengina turkmenica. Similar to the thiopeptide and HCA clusters, haloazolisin gene 
clusters encode a truncated, fused CD cyclodehydratase (missing roughly 200 amino acids from 
the N-terminus); however, the precursor peptide binding region is also missing from the F-like 
protein. Therefore, it is suspected that another uncharacterized protein within the cluster would be 
responsible for leader peptide binding, if these clusters do indeed generate a TOMM.  
The haloazolisin precursor peptides are highly divergent, suggesting that this family may 
produce additional TOMMs. We identified 31 precursor peptides in these clusters with most 
having a Ser-rich core region (Figure 2.8). These clusters offer not only a wealth of potential 
novel TOMM structures and modification machinery, but also provide the opportunity to 
characterize natural product biosynthesis in archaea, which has been largely overlooked. 
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2.4.6 Thermoacidophisin 
An additional archaeal family of TOMMs was identified in the genus Sulfolobus, 
specifically strains of S. acidocaldarius and S. islandicus. Four other related clusters were 
discovered in bacterial organisms, Thermoanaerobacter mathranii subsp. mathranii Str. A3, 
Actinomyces odonolyticus F0309, Bacillus cereus Rock3-44 and Caldisericum exile DSM 21853. 
All of these clusters have discrete cyclodehydratases, and their D proteins are most closely related 
to the helicobactin and PZN proteins (Figures 2.5 and 2.6), while the C proteins make up a single 
group of proteins unrelated to other C proteins (Figure 2.9, group not shown).  The 
thermoacidophisin gene clusters also contain a B protein, ABC transporters, a regulator, and 
many hypothetical proteins (Figure 2.7).  
Precursor peptides were identified for four of the thermoacidophisin clusters, all of which 
contain an abundance of Tyr and Gly residues. Characterization of these archaeal and bacterial 
TOMMs will potentially provide insight into the evolution of TOMM biosynthesis and horizontal 
transfer. The thermoacidophisin cluster has clearly disseminated over large phylogenetic 
distances through horizontal gene transfer, as it is present in four different phyla (Crenarchaeota, 
Firmicutes, Actinobacteria, and Caldiserica). Interestingly, three of the five strains that contain 
this particular cluster are known thermophiles despite residing in different phyla.  
2.4.7 Gallolytisin 
A few presumed isofunctional clusters have exceptionally unique precursor peptide 
sequences and gene composition. The gallolytisins are TOMMs encoded by a subset of only 20 
strains, including Streptococcus gallolyticus. These clusters contain a discrete cyclodehydratase, 
and the D proteins are most similar to the D proteins from the PZN cluster (Figures 2.5 and 2.6). 
The C proteins from these clusters form a separate clade when compared to all other modification 
enzymes (Figure 2.9, group not shown). The gallolytisin clusters also contain ABC transporters 
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and a regulator (Figure 2.7). Seven gallolytisin precursor peptides were identified, all of which 
contain a highly conserved CCCCXCCCC motif, where X is Pro, Ala, or Asp (Figure 2.8). 
2.4.8 Anabaenasin  
Anabaenasins are encoded by 11 varied species. Their gene cluster contain a discrete 
cyclodehydratase; with a D protein most similar to the D proteins from the haloazolisin and 
mobilisin gene clusters and a unique C protein (Figure 2.9, group not shown). Surprisingly, the 
cluster from Anabeana sp. 90 contains a transposase gene directly between the C and D proteins, 
suggesting that these clusters could be either mobile or inactive. This cluster architecture is not 
conserved within all of the anabaenasin family members. Five precursor peptides were identified 
in these clusters, all of which are Gly and Cys rich. 
2.4.9 Coryneazolisin type 1 and type 2 
The strains of Corynebacterium associated with TOMM clusters are all disease-causing, 
including C. diphtheriaea, C. ulcerans, and C. pseudotuberculosis. Although prominent AB 
toxins from these strains have been characterized,(Pappenheimer 1977) the TOMMs from these 
classes have not, and as such, it remains unknown whether these coryneazolisins play a role in 
pathogenesis akin to SLS (Molloy, et al. 2011).  These gene clusters contain two D proteins 
which form distinct groups; one discrete (type 1) and one that is fused with a C protein (type 2) 
(Figure 2.3). The coryneazolisin clusters also contain lanthipeptide-like dehydratases, and similar 
to goadsporin, they lack the canonical [4+2] cycloaddition protein common to the thiopeptides, 
suggesting that these coryneazolisins are not macrocyclic (Figure 2.7).  
Precursor peptides were identified in 24 coryneazolisin gene clusters. These precursor 
peptides are highly similar to each other, with only a single substitution in the leader region 
among them; however, they differ significantly from other TOMMs, making it difficult to predict 
the final product. The core region contains 10 Cys/Ser/Thr residues followed by an Ile, then 5-7 
additional Cys/Ser/Thr residues (Figure 2.8). A subset of coryneazolisin gene clusters do not 
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contain identifiable precursor peptide or cyclodehydratase genes, suggesting that they may be 
inactive. Furthermore, these clusters are surrounded by transposable elements, and in some cases 
the D protein is fused to a transposable element, which can be indicative of horizontal gene 
transfer (Figure 2.12 
2.5 Distribution of TOMM Gene Clusters 
Transfer of biosynthetic gene clusters has been previously discussed for many natural 
products. Although horizontal gene transfer of TOMMs has not been extensively studied, it is 
intriguing that many biosynthetic gene clusters contain or are flanked by transposase genes, 
remnants of transposable elements or tRNA genes. Although not a predominant group of genes 
identified in TOMMs, there are transposase genes found in the proximity of HCA, PZN, 
cyanobactin, hakacin, cytolysin, NHLP, faecalisin, microcin B17, thermoacidophisin, thiopeptide 
and coryneazolisin clusters (Figure 2.9, Groups 49, 51, 71, 77 and 78). This suggests a potential 
mechanism for gene cluster transfer between organisms. 
To explore the distribution and transmission of TOMM clusters, a phylogenetic tree was 
created using the 16S sequences from each TOMM producing organism. The TOMM clusters 
produced by each organism were then mapped onto the tree (Figures 2.13 and 2.14). TOMM gene 
clusters are found in 6% of bacteria and 35% of archaea among the sequenced organisms in 
Ensembl. At first glance, the Firmicutes appear to be the major producers of TOMMs. While 
Firmicutes may encode the greatest number of TOMM gene clusters, many are extremely similar 
(e.g. the HCA and cytolysin clusters). Most TOMM diversity is presented by other phyla, such as 
the Proteobacteria, Actinobacteria and Euryarchaea. Although similar TOMM families are most 
often produced by related organisms, there are striking examples of possible horizontal 
transmission of a TOMM between distantly related organisms. For example, the cytolysins are 
primarily found in Firmicutes (Streptococcus, Clostridium, Listeria, etc.), but they are also 
present in Spirochaetes (Brachyspira, Borrelia, etc.). When assessed in vitro, the cytolysin from 
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Borrelia did possess a similar hemolytic phenotype as that of streptolysin S (Molloy et al., 
submitted). In addition, thermoacidophisin-like clusters are found in Crenarchaeota, Firmicutes 
and Actinobacteria, suggesting these clusters may have be transferred between archaea and 
bacteria.  
2.6 Summary and Outlook 
This study characterized the database containing genomic complexity of TOMM natural 
product biosynthetic gene clusters. An in-depth analysis of TOMM clusters was used to identify 
nine novel TOMM families, as well as identify the predominant accessory enzymes that bestow 
additional structural diversity. Precursor peptides were also analyzed for sequence diversity 
within each class. This study revealed the diversity of TOMM clusters as well as the phylogenetic 
distribution of clusters in not only bacteria, but also archaea. With the geometric expansion in the 
rate of genome sequencing, it is expected that TOMM cluster diversity will increase as well, 
providing a large and growing source of new enzymes and natural products with potential 
medical or industrial implications.  
2.7 Experimental 
All YcaO domain-containing proteins (InterPro IPR003776, D protein) were obtained 
from InterPro on October 28th, 2014. An attempt was made to include all YcaO domain-
containing proteins that have been sequenced, but many protein sequences from NCBI were not 
correlated with genomes or were not added to UniProt and therefore were not included in the 
characterization. 
2.7.1 Biosynthetic gene cluster discovery and comparison  
10-kb genomic regions on either side of the YcaO domain-containing proteins were 
obtained from NCBI, and predicted protein sequences were used as annotated. Genome regions 
were clustered using MultiGeneBlast (Blin, et al. 2013, Medema, et al. 2011). The database used 
was created from all of the genomic regions obtained from NCBI. 100 BLAST hits were mapped 
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with a synteny conservation hit weight of 0.5 and a BLAST hit weight of 0.5. The minimal 
BLAST sequence coverage was 25 and the minimal percent identity for BLAST hits was 30%. 
Genomic regions with a MultiGeneBlast score above 10 were grouped into families.  
To identify TOMM biosynthetic gene clusters, profile Hidden Markov Models (pHMMs) 
and the program HMMER (Finn, et al. 2011) were used to identify C proteins from TOMM 
clusters. TIGR03603 and TIGR03882 were used to identify C proteins and CD fusion proteins, 
respectively. New pHMMs were created to identify short CD fusions similar to those in the 
haloazolisin clusters. Precursor peptides were identified as described below. Genomic regions 
were considered TOMMs if any members of the families identified with MultiGeneBlast 
contained a C or CD fusion protein identified with the pHMMs, the genomic region contained a 
precursor peptide (described below), or the genomic regions clustered with known bottromycin 
producers (Crone, et al. 2012, Gomez-Escribano, et al. 2012, Hou, et al. 2012, Huo, et al. 2012) 
(a TOMM with no identifiable C protein and a non-canonical precursor peptide). 
2.7.2 Sequence similarity networks 
The D proteins from all of the identified TOMM gene clusters were used to make the D-
only sequence similarity networks. Similarity was evaluated using an all-vs-all BLAST ith an e-
value cutoff of E-54. To create the network with all of the TOMM proteins, proteins were 
predicted from NCBI gene annotations. All proteins within the genomic region were submitted to 
the Enzyme Function Initiative – Enzyme Similarity Tool (enzymefunction.org) for analysis. The 
similarity was calculated at an e-value of E-30 with a representative node cluster of 100%. Both 
networks were visualized with Cytoscape (cytoscape.org) using the organic layout. 
2.7.3 Precursor sequence discovery  
Precursor peptides were identified using two methods. In one, the NCBI-annotated genes 
from all of the genomic regions surrounding a YcaO domain-containing protein were analyzed, 
and any genes smaller than 450 bp were considered precursor peptides if the residues in the C-
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terminal half of the encoded product were at least 45% Cys, Ser, or Thr. Because gene annotation 
programs often have difficulty annotating small open reading frames, the second method first 
determined all possible open reading frames in each genomic region. Any potential protein under 
150 amino acids with at least 65% of the residues in the C-terminal half being Cys, Ser, or Thr 
were considered precursor peptides. Duplicates were removed. Precursor peptides vary in both 
sequence and length, and therefore, it is likely that many precursor peptides remained 
unidentified using this stringent method. Furthermore, any precursor peptides encoded elsewhere 
in the genome would be left unannotated with this analysis, as is the case with many HCA 
precursor peptides.   
2.7.4 Phylogenetic analysis  
D protein sequences were obtained from UniProt, and 16S rRNA sequences were 
obtained from SILVA by searching for the organism name from UniProt. All phylogenetic 
analysis was done using Molecular Evolutionary Genetics Analysis (MEGA) (Tamura, et al. 
2013). Sequences were aligned using MUSCLE (Edgar 2004, Edgar 2004, Goujon, et al. 2010, 
McWilliam, et al. 2013) with all standard parameters. Maximum likelihood phylogenetic trees 
were created in MEGA using the standard parameters. 
  
50 
 
2.8 Figures 
 
Figure 2.1 | Schematic of bioinformatics analysis. (A) TOMM biosynthesis begins with the 
ribosomal synthesis of a precursor peptide. The characteristic thiazoline/oxazoline heterocycles of 
a TOMM are installed by the C and D protein complex colored green and blue, respectively. Other 
tailoring enzymes (red and teal) often install additional modifications on the maturing product 
before the proteolytic cleavage (orange) of the leader peptide. (B) To identify TOMMs, all proteins 
containing a YcaO domain were identified using InterPro (IPR003776). The genomic regions 
surrounding the YcaO domains were retrieved, analyzed, and grouped by their cumulative BLAST 
bit score and synteny (Step 1). TOMM clusters were then separated from non-TOMM gene clusters 
determined by the inclusion of a C protein, precursor peptide, or bottromycin-like D protein (Step 
2). (C) BLAST and synteny values from MultiGeneBlast were used to group TOMM clusters (Step 
1). (D) A gene cluster was classified as a TOMM if it contained a C protein, precursor peptide, or 
was similar to bottromycin (Step 2).  
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Figure 2.2 | Structures of a representative group explored TOMM compounds. Chemical 
structures from a few of the major classes of known TOMMs. Compound names and activities are 
listed below each structure. 
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Figure 2.3 | Sequence similarity network of TOMM D-proteins. Each node represents a unique 
D protein (YcaO, from InterPro family IPR003776), while an edge indicates that two proteins have 
a BLAST expectation value < 1E-54.  All nodes belonging to TOMM families with at least one 
characterized gene cluster (structure of final product not necessary) are colored as noted in the 
legend. Black isofunctional groups indicate that no member of the group has been characterized. 
  
53 
 
 
Figure 2.4 | Sequence similarity network of TOMM D proteins. Each node represents a unique 
D-protein, while an edge indicates that two proteins have a BLAST expectation value < 1E-54.  All 
nodes from uncharacterized TOMM families are colored as noted in the legend. All nodes in 
TOMM families with at least one characterized gene cluster (structure of final product not 
necessary) are colored black. 
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Figure 2.5 | Phylogenetic analysis of TOMM D proteins. A maximum likelihood tree was 
constructed using the D protein sequence from all TOMM producers. The class of characterized 
TOMM was then mapped on with colored circles as represented in the legend. Similar TOMM 
clusters seen in the sequence similarity network (Figure 2.3) are seen grouping here.  
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Figure 2.6 | Phylogenetic analysis of TOMM D proteins. A maximum likelihood tree was 
constructed using the D protein sequence from all TOMM producers. The class of uncharacterized 
TOMM was then mapped on with colored circles as represented in the legend. Similar TOMM 
clusters seen in the sequence similarity network (Figure 2.3) are seen grouping here. This tree is 
identical to the tree from Additional File 3: Figure S3, but with different colors mapped onto the 
tree for identification of the uncharacterized TOMM classes. 
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Figure 2.7 | Representative gene clusters from each TOMM subclass. Open reading frame 
diagrams are shown for a representative organism of each TOMM family. Uncharacterized gene 
clusters represent subclasses of TOMMs from which no gene clusters that have explored. 
Characterized clusters represent subclasses from which at least one gene cluster has been explored.  
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Figure 2.8 | Sequence logos from bioinformatically identified TOMM precursor peptides. 
Sequence logos were created (WebLogo) using the C-terminal region of identified precursor 
peptides (cleavage sites were estimated based on length and the presence of a glycine or alanine 
residue as seen in other TOMM precursor peptides). Cysteines are labeled in red, serines in blue, 
threonines in green, and other amino acids in black. 
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Figure 2.9 | The prevalence and distribution of enzymes involved in TOMM biosynthesis. A 
sequence similarity network was constructed with all proteins in the TOMM biosynthetic gene 
clusters visualized at a BLAST expectation value of 1E-30. All proteins with 100% identity were 
removed and are represented as larger nodes on the network (size is dependent on the number of 
redundant proteins). Groups are number for reference within the manuscript. 
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Figure 2.10 | The prevalence and phylogenetic distribution of enzymes involved in TOMM 
biosynthesis. A sequence similarity network with all proteins in the TOMM biosynthetic gene 
clusters visualized at an e-value of 1E-30. All proteins with 100% identity were removed and are 
represented as larger nodes on the network (size is dependent on the number of removed proteins).  
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Figure 2.11 | The prevalence and phylogenetic distribution of enzymes involved in TOMM 
biosynthesis. A sequence similarity network with all proteins in the TOMM biosynthetic gene 
clusters visualized at an e-value of 1E-30. All proteins with 100% identity were removed and are 
represented as larger nodes on the network (size is dependent on the number of removed proteins). 
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Figure 2.12 | Inactivated coryneazolisin cluster comparisons. Gene clusters from four potential 
coryneazolisin clusters are depicted. The two topmost clusters contain all the predicted enzymes 
required for coryneazolisin production. The second cluster from the top contains an additional 
transposase gene on the end. The third cluster is truncated and surrounded by transposable 
elements, and the fourth cluster contains a D protein that has been fused to a transposable element. 
It is likely that the two bottommost clusters have been inactivated.   
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Figure 2.13 | Phylogenetic analysis of TOMM producers. A maximum likelihood tree was 
constructed using 16S sequences from all organisms that contain a TOMM gene cluster. Coloring 
indicates which class of TOMM that particular organism contains, per the legend. The phyla of the 
producing organisms are labeled around the tree. Most classes of TOMMs appear to be produced 
within the same phylum; however, some classes are found in multiple phyla.  
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Figure 2.14 | Phylogenetic analysis of TOMM producers with uncharacterized clusters. A 
maximum likelihood tree was constructed using 16S sequences from all TOMM producers. This is 
the same tree produced in Figure 6, but with different TOMM classes mapped on with colored 
circles as represented in the legend. The phyla of the producing organisms are labeled around the 
tree. Most families of TOMMs appear to be produced within the same phylum; however, some are 
produced in multiple phyla. 
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CHAPTER III: TOMM BIOSYNTHESIS IN ARCHAEA 
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Abstract 
Natural product biosynthesis in the domain archaea has been virtually unexplored, 
leaving their biosynthetic capabilities poorly characterized compared to bacteria and eukaryotes. 
The thiazole/oxazole-modified microcins (TOMMs) are posttranslationally modified peptides 
encoded in the domains bacteria and archaea. A trimeric enzymatic complex, from the TOMM 
biosynthetic gene cluster, is responsible for installing heterocycles on the TOMM peptides. These 
heterocycles are formed from cysteine, serine, and threonine residues of the precursor peptide(s). 
A putative TOMM cluster in the archaeal species Sulfolobus acidocaldarius was discovered 
through genome mining. As microbial genome sequences continues to accelerate, biosynthetic 
clusters remarkably similar to that of the S. acidocaldarius TOMM have been catalogued in other 
archaeal and bacterial species. A multipronged approach was used to identify and characterize the 
natural product(s) produced by these similar TOMMs. These characterizations gave fundamental 
insight into the biosynthesis and evolution of gene clusters within archaea. The natural product(s) 
were not identified, illuminating the difficulties inherent with genome guided natural product 
discovery methods. This work encouraged the creation of a novel genome guided technique to 
identify and isolate compounds which is discussed further in chapter 4.  
3.1 Introduction 
Antibiotics have been an important tool for innovation in both the basic science and 
medical fields (Falconer, et al. 2011, Peric-Concha, et al. 2003). However, with the sharp decline 
in the discovery of novel antibiotics during the last few decades, coupled with a rise in antibiotic 
resistant bacteria, it has become imperative to take alternate steps to discover new antibiotics 
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(Clatworthy, et al. 2007). Genomic sequencing has revealed a tremendous diversity in microbial 
species and their biosynthetic capabilities, which include a vast array of bioactive natural 
products. Although many bacterial natural products have been extensively studied (Clardy, et al. 
2006, Walsh 2004), the prevalence of antimicrobial natural products from the domain archaea is 
still largely unknown. Characterization of gene encoded, archaeal, toxic polypeptides, termed 
archaeocins, remains in the early stages (O'Connor, et al. 2002). Halocins are archaeocins 
produced by halophilic euryarchaea and the few studied vary widely in both biochemical 
characteristics and biological activities (Haseltine, et al. 2001). Halocins are secreted into the 
media and range in size from 3.5 kDa (considered microhalocins) to 35 kDa (Cheung, et al. 1997, 
Price, et al. 2000). Five microhalocins have been structurally characterized, none of which 
undergo posttranslational modification (Shand 2008). The activity spectrum of halocins is broad, 
with toxins killing not only closely related haloarchaea, but also non-related hyperthermophilic, 
crenarchaeal Sulfolobus species (Haseltine, et al. 2001). Sulfolobicin, a relatively large 
archaeocin (20 kDa), is produced by the Sulfolobales order (Ellen, et al. 2011, Leyva 2008, 
Prangishvili 2000). This archaeocidal toxin is encoded by two separate proteins that form a 
complex and associate with spherical vesicles which are secreted by the producer strain (Ellen, et 
al. 2011). The activity spectrum of sulfolobicin is narrow, with only S. solfataricus P1, S. 
shibatae B12 (DSM 5389), and six strains of S. islandicus inhibited (Prangishvili 2000). 
Interestingly, these sulfolobicins are extremely stable, resistant to high temperature and varying 
pH, as well as long term storage (Ellen, et al. 2011). A cypemycin-like biosynthetic gene cluster 
has also been described in the archaeal species Haloterrigena turkmenica DSM 5511, however 
the product of this cluster has not been experimentally investigated (Claesen, et al. 2010). 
Research on the archaeocins, especially those with unknown functions and activities, will lead to 
a better understanding of archaeal competition and secondary metabolism (O'Connor, et al. 
2002). Since archaea employ eukaryotic-like cellular processes and can live in such varied 
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environments, some archaeal natural products may have distinct functions relative to those 
produced by bacteria. Bioactive, structurally complex molecules from thermoacidophiles (i.e. S. 
acidocaldarius TOMM) could potentially be pharmaceutically valuable, as they would be 
expected to have properties protecting them from both enzymatic and non-enzymatic degradation 
within patients. 
3.1.1 Thiazole/oxazole-modified microcins 
In the search for new bioactive compounds, genome sequencing has revealed a widely 
distributed biosynthetic gene cluster that posttranslationally modifies inactive, peptides to yield 
bioactive natural products (Lee 2008, Melby, et al. 2011). This class of natural products has been 
termed the thiazole/oxazole modified microcin (TOMM) family. TOMMs are characterized by 
the installation of heterocycles that are derived from Cys, Ser and Thr residues in the precursor 
peptide (A). A trimeric complex containing a cyclodehydratase (C and D protein) and 
dehydrogenase (B), cooperatively act to install heterocycles onto precursor peptides (Figure 
3.1A). The cyclodehydratase performs the cyclization of Cys and Ser/Thr residues to form 
thiazoline and (methyl)oxazoline heterocycles (Belshaw, et al. 1998, Dunbar, et al. 2012, Dunbar, 
et al. 2013, Li, et al. 1996, Melby, et al. 2012, Milne, et al. 1998, Milne, et al. 1999). A subset of, 
or sometimes all, “azoline” heterocycles are then further processed by a flavin mononucleotide 
(FMN)-dependent dehydrogenase, to produce the aromatic thiazole and (methyl)oxazole 
heterocycles (Melby, et al. 2014) (Fig. 3.1B). These heterocycles endow the precursor peptide 
with a rigidified structure necessary for activity. TOMM biosynthetic clusters often contain 
ancillary tailoring enzymes to increase structural complexity and transporters to export the fully 
functional natural product out of the cell.  
The TOMM family is widely disseminated in both bacterial and archaeal species. 
Computational surveys have identified over 400 clusters in the genomes published in GenBank as 
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of 2012. Examples of studied TOMMs include microcin B17 (DNA gyrase inhibitor), streptolysin 
S (cytolysin), heterocycle-containing cyanobactins (eukaryotic cytotoxins), and the thiopeptides 
(ribosome inhibitors) (Melby, et al. 2011). Despite extensive characterization of some TOMMs, 
the vast majority have unknown structures and bioactivities (Figure 3.2). As of 2012, Sulfolobus 
acidocaldarius is one of three archaeal species which was discovered to contain a “complete” 
TOMM cluster (contains ‘A’ precursor and ‘BCD’ modifying proteins). There are 14 archaeal 
species that contain an incomplete cluster with only the ‘CD’ modifying enzymes. Thus, these 
clusters would be expected to produce compounds with exclusively azoline (not azole) 
heterocycles, unless a dehydrogenase encoded elsewhere in the genome is operative. Given our 
previous successes in studying TOMM biosynthetic clusters (Lee 2008, Mitchell 2009) and our 
current interests in defining the biosynthetic capabilities of the archaea, S. acidocaldarius 
provides a unique opportunity to explore this exciting area. 
3.1.2 Sulfolobus acidocaldarius TOMM cluster 
S.acidocaldarius is a well-known archaeal species that was first isolated from a hot 
spring in Yellowstone National Park (Brock 1972). S. acidocaldarius thrives in environments 
with temperatures ranging between 75 - 90 ºC and a pH of 2-3. These living conditions make S. 
acidocaldarius one of the few thermoacidophiles known. While much is known about S. 
acidocaldarius relative to other archaeal species, our molecular understanding of this organism, 
and the archaea as a whole, pales in comparison to bacteria. Archaea are morphologically more 
similar to bacteria, but employ eukaryotic-like mechanisms for cellular processes (Whitman, et 
al. 1999). Other defining features of the domain archaea include a lack of peptidoglycan in their 
cell walls (S. acidocaldarius replaces peptidoglycan with a S-layer) and membranes composed of 
ether-linked lipids (Taylor, et al. 1982, Woese, et al. 1990). Not only are archaea globally 
underrepresented in microbiological research, but the challenge of culturing and creating genetic 
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systems in archaeal species has delayed the exploration of their natural product biosynthetic 
capabilities.  
The predicted S. acidocaldarius TOMM biosynthetic gene cluster is comprised of eleven 
genes (Figure 3.3). Because of its similarity to other TOMM clusters, we have adopted the 
standard TOMM nomenclature for most of the encoded proteins. There are two predicted 
precursor peptides in the cluster that harbor four and six heterocyclizable residues, SaciA1 and 
SaciA2 (Saci_0528 and unnanotated, respectively) (Figure 3.3). The genes that encode for 
SaciA1and SaciA2 are followed in the cluster by saciBCD (Saci_0525, Saci_0527, Saci_0526, 
respectively), which are orthologous to the thiazole/oxazole synthetase proteins in other TOMM 
clusters and are expected to carry out the same transformation. A predicted immunity gene is 
present, designated saciF (Saci_0530), which is weakly similar to suspected immunity proteins in 
other TOMM clusters. There are three ABC transporter genes within the cluster, saciGHI 
(Saic_0532, Saci_0531 and Saci_0529, respectively). SaciK (Saci_0523) is a predicted 
transcriptional regulator, which belongs to the ArsR family of repressors. The last gene in the 
cluster, saciJ (Saci_0524), has an unknown function and is only homologous to an annotated gene 
in the Sulfolobus islandicus REY15A TOMM cluster. The predicted TOMM(s) from S. 
acidocaldarius are unique when compared to other archaeocins and will be the first extensively 
posttranslationally modified natural products studied in archaea.  
3.1.3 Other related TOMM clusters 
Our lab has shown, by using bioinformatics-guided chemotyping that TOMMs cluster by 
their putative function. For this analysis, we created a phylogenetic tree of the D proteins (Figure 
3.2) (Melby, et al. 2011). This is a powerful analysis, as it allows the functional prediction of 
uncharacterized TOMMs based on their similiarity to a relative with a known function. In the 
cases where no phylogenetic neighbors have a known function, no prediction can be made. The S. 
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acidocaldarius TOMM falls into this category, as it forms a new clade with other TOMMs of 
unknown function. A bioinformatics study using SaciBCD proteins was performed to determine 
TOMMs that will likely have similar functions and to find the evolutionary distribution of this 
cluster (Figure 3.4). Four other highly related clusters were discovered (Figure 3.3). The cluster 
from Sulfolobus islandicus REY15A was used in comparison with the S. acidocaldarius to 
determine the boundaries of these clusters. Interestingly, three other related clusters were 
discovered in bacterial species. The other clusters are in Bacillus cereus Rock3-44, 
Thermoanaerobacter mathranii subsp. mathranii str. A3, and Actinomyces odonolyticus F0309. 
These bacterial species have precursor peptides that likely function similarly to S. acidocaldarius 
and S. islandicus (Figure 3.3), and provide a possible pathway for acquisition of these clusters 
through horizontal gene transfer.  
3.2 Multipronged Approach 
To identify and characterize the S. acidocaldarius TOMM biosynthetic gene cluster and 
natural product(s) a multipronged approach was taken. Multiple genome guided techniques that 
had been previously used study other ribosomally produced natural products were enlisted to 
elucidate the structure and biological activity of the S. acidocaldarius TOMM. The necessary S. 
acidocaldarius TOMM biosynthetic genes were cloned into E. coli expression vectors, expressed 
and purified. This work set the stage for in vitro reconstitution, structural characterization using 
MS, and functional characterization of the enzymes and natural product(s). For an in vivo 
approach, reverse transcriptase (RT)-PCR, a gene deletion, and fosmid-based heterologous 
expression was used to serve as a guide for the isolation of the S. acidocaldarius TOMM natural 
product(s). These techniques had all previously been used to identify other ribosomal natural 
products, however were unsuccessful when used to identify the TOMM from S. acidocaldarius. 
Often natural products are produced in extremely low levels or are not produced in laboratory 
culturing conditions and this is likely the reason the following techniques did not work in 
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isolating the S. acidocaldarius TOMM. However, these setbacks stimulated the creation of a new 
method that evaded this common difficulties resulting in the discovery of a different natural 
product (discussed in chapter 4). 
3.3 Heterologous Expression and Purification of the S. acidocaldarius TOMM Proteins 
In vitro assays provide an unparalleled method to study enzymatic reactions through the 
precise control of reaction conditions. To study the heterocycle formation within the two 
precursor peptides, SaciA1 and SaciA2, an in vitro synthetase reaction similar to previous reports 
(Lee 2008, Sinha Roy, et al. 1998) was attempted. To perform these experiments, the necessary 
genes (saciA1, A2, B, C, and D) were cloned from genomic DNA into the pET28-maltose binding 
protein (MBP) fusion E. coli expression vector. MBP was used for affinity purification of the 
proteins and to enhance their solubility/stability. The expression and purification of the S. 
acidocaldarius TOMM biosynthetic proteins (Figure 3.5) was successful, except for SaciD, 
which remained largely insoluble under all tested conditions and was unusable in the 
reconstitution of heterocycles. As shown with other systems, highly related non-cognate ‘BCD’ 
enzymes often have the ability to posttranslationally modify similar precursor peptides (Lee 2008, 
Mitchell 2009). Knowing this, attempts to clone the D protein from closely related TOMM 
clusters in B. cereus and T. mathranii were perfomed. 
3.4 Heterologous Expression of the Bacillus cereus Rock3-44 TOMM Proteins  
The B. cereus TOMM cluster was discovered via a bioinformatics search looking for 
closely related enzymes to the S. acidocaldarius TOMM cluster. The B. cereus D protein 
(RockD) is 58.4% similar to SaciD (Figures 3.4 and 3.6) and thus was considered as a substitute 
for SaciD for in vitro reactions. All of the essential TOMM proteins (RockA, B, C, D) from B. 
cereus were also cloned into the pET28-maltose binding protein (MBP) fusion E. coli expression 
vector. As with the S. acidocaldarius proteins, RockA was affinity purified using immobilized 
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amylose resin. Unfortunately, RockD was also insoluble and unable to install heterocycles onto 
the precursor peptides during in vitro reconstitution. 
3.5 MS of Unmodified Precursor Peptides 
Previously characterized TOMM natural products have been successfully studied using 
MS (Matrix-assisted laser desorption/ionization (MALDI)-time of flight (TOF) and electrospray 
ionization) techniques (Kelleher, et al. 1998). During the formation of each azoline ring (formally 
a cyclodehydration), 18 Da is lost from the parent peptide. Each subsequent dehydrogenation (-
H2) leads to an additional loss of 2 Da (Figure 3.1B). This loss in mass permits the use of MS-
based assays for monitoring heterocycle formation on the precursor peptide. Using MALDI-TOF, 
the masses, of unmodified SaciA1, SaciA2, and RockA were measured (Figure 3.7). Tobacco 
Etch Virus (TEV) protease was used to cleave the precursor peptides from MBP leaving the final 
masses at 5207.9 Da, 4587.4 Da, and 4474.2 Da, respectively. Unfortunately, functional D 
protein was not obtained and therefore further characterization of heterocycle formation within 
the precursor peptides was never performed. Heterologous production of modification machinery 
can be very challenging, particularly when expressing proteins within a host that is dissimilar and 
therefore we identified other methods that could be used to characterize the natural product within 
the native host. 
3.6 RT-PCR 
Although reaction conditions can be carefully monitored and controlled during in vitro 
reconstitution studies, they do not always accurately represent physiological conditions within the 
producing organism. Combined with the possibility that other modifying enzymes are necessary, 
but not present during in vitro reconstitution assays, it is important to complement in vitro studies 
with in vivo data. Understanding this, I am pursued the isolation of the natural product(s) from the 
native host. RT-PCR was used to first demonstrate that the native producer was actively 
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transcribing the TOMM genes during laboratory cultivation (Figure 3.8). For this experiment, 
RNA was isolated from S. acidocaldarius cultures grown into late log phase, in liquid DT media 
(dextrin and tryptone, pH 3.5, 80⁰C). mRNA was then converted to cDNA using reverse 
transcriptase and the cDNA was probed for transcription with S. acidocaldarius TOMM specific 
primers. All genes within the cluster were transcribed. This indicated that there was a possibility 
of the natural product(s) being produced by S. acidocaldarius and therefore I pursued isolation 
from the native producer.  
3.7 Gene Deletion Strains  
Creation of a gene deletion strain has been previously used to facilitate the study and 
isolation of the mature TOMM natural product(s). By comparing HPLC and MS traces between a 
gene deletion strain and the parent strain, the molecular weight of the TOMM natural product(s) 
can be determined. The mass can aid in structural elucidation of the product because of the 
distinct weight change associated with each heterocycle formed. These gene deletions can also be 
coupled with the function of the peptides when employing activity assays. The complete 
maturation, and thus the activity, of the peptide should be lost when the deletion strains are tested.  
A pyrimidine auxotroph strain of S. acidocaldarius was used to generate a deletion strain. 
A spontaneous mutation in the pyrE gene renders the strain MR31 deficient in pyrimidine 
biosynthesis, and therefore unable to replicate their DNA in the absence of supplemental uracil 
(Figure 3.9B). MR31 has an in-frame deletion and therefore the adjacent downstream gene, pyrF, 
is unaffected in transcription (Figure 3.9A). Disruption of SaciC was targeted with homologous 
recombination (Figure 3.9C) using a plasmid containing a pyrE gene from S. islandicus and its 
upstream and downstream elements, flanked by regions of saciC. Importantly, the pyrE gene in 
the plasmid is not identical to wild type pyrE gene, which prevents untargeted homologous 
recombination with the native pyrE gene. Mutants were selected for in media lacking uracil. 
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Mutants with a restored functional pyrE gene were able to grow in the absence of uracil 
supplementation. After transformation with the plasmid, two deletion strains were identified by 
PCR screening as these strains have an approximately 400 base pair increase in PCR amplicon 
size when amplifying with saciC primers, which anneal to the outer limits of the saciC gene. LC-
MS was used to compare the gene deletion strain and the wild type strain in growth conditions 
identified using RT-PCR. These comparative analyses were unable to identify differences in the 
spectra between the two strains. Therefore it is likely that the natural product(s) are produced in 
vanishingly small amounts or are not produced at all during laboratory cultivation. 
3.8 Fosmid Library Generation 
Complimentary to the creation of the above deletion strain, the production of a fosmid 
that contains the S. acidocaldarius TOMM cluster was also created to facilitate the isolation of 
the natural product(s). In this sense, when using comparative LC-MS to identify the natural 
product(s) a peak gained gained in the fosmid-bearing strain is expected when compared to the 
parent strain. I created a fosmid library from S. acidocaldarius genomic DNA using the fosmid 
pJK050. After PCR screening approximately 2000 colonies, I identified and isolated four fosmid 
strains: two contain the entire TOMM cluster and two contain partial clusters. I used the fosmid 
strain pCOX6E6 for further studies. This fosmid contained the entire TOMM cluster, but has the 
smallest amount of excess S. acidocaldarius chromosomal DNA. Using RT-PCR, I verified all of 
the core TOMM genes (saciA1, A2, B, C, D) are expressed. As with the gene deletion strains, 
comparative studies with the empty fosmid did not lead to the identification of the natural 
product(s). Similar to the heterologous expression, these proteins (the D protein in particular) are 
likely not expressed in E. coli and therefore the natural product was not visualized. 
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3.9 Summary and Outlook 
Natural product biosynthesis in the domain archaea has been overlooked. This project 
aimed to shed light on this unexplored area by studying the biosynthesis of a TOMM natural 
product from Sulfolobus acidocaldarius. This work had the potential to fundamentally shift the 
current perception that archaea are not capable of complex molecule biosynthesis. Furthermore, 
this TOMM biosynthetic gene cluster would represent the first posttranslationally modified 
natural product to be characterized in the domain archaea. The identification of the S. 
acidocaldarius family of TOMMs demonstrated the power of genome mining for the 
identification of novel biosynthetic gene clusters. However, characterization of this family 
verified the difficulty of natural product discovery, even when a gene cluster has been identified. 
Although genome mining has the potential to prevent identification of known compounds, 
techniques to identify compounds from a particular gene cluster still pose a difficult problem for 
researchers. Although many techniques have been created for genome based isolation, the 
characterization of the S. acidocaldarius TOMM natural products indicates the difficulties in 
identifying compounds from a particular cluster. Therefore I proceeded to identify novel and 
rapid techniques to correlated natural products with genome guided identification of biosynthetic 
gene clusters.  
3.10 Experimental 
3.10.1 Protein overexpression and purification 
All proteins were overexpressed as tobacco etch virus (TEV) protease fusions to maltose-
binding protein (MBP) and purified by amylose affinity chromatography as previously reported 
(Dunbar, et al. 2012). All characterizations of the proteins were performed with the tagged 
substrates, with the exception of the MS analysis of the precursor peptides SaciA1, SaciA2, and 
RockA.  
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3.10.2 MALDI-TOF mass spectrometric analysis of the precursor peptides 
MALDI-TOF mass spectrometry was performed using a Bruker Daltonics 
UltrafleXtreme MALDI-TOF/TOF instrument operating in positive reflector mode. The 
instrument was calibrated before data acquisition using a commercial peptide calibration kit 
(AnaSpec – Peptide Mass Standard Kit). Analysis was carried out with Bruker Daltonics 
flexAnalysis software. The precursor peptides were incubated in the presence of TEV protease 
overnight to remove the fusion proteins. The peptides were purified using a ZipTip purification 
system and eluted with 10 µL of 95% aqueous acetonitrile. 2 µL of this peptide solution was 
mixed with 2 µL of matrix solution (a saturated solution of α-cyano-4-hydroxycinnamic acid), 
spotted on the target, air dried and measured as stated above.  
3.10.3 Sulfolobus cultivation conditions 
S. acidocaldarius was cultivated in a tissue culture flask at 78°C without shaking. DT 
medium (pH 3.5), was used for cultivation. DT medium contains the following components (in 1 
liter Milli-Q H2O): 1x basal salts (CaCl2 · 2H2O, 0.1 g; K2SO4, 3.0 g; MgSO4, 0.145 g; and 
NaH2PO4, 0.5 g), 20 µL trace mineral stock solution (0.5% CoCl2 · 6H2O, 0.5% CuCl2 · 2H2O, 
3.0% FeCl3 , 0.5% MnCl2 · 4H2O, and 0.5% ZnCl2), 0.1% (wt/vol) dextrin, and 0.1% (wt/vol) 
EZMix-N-Z-amine A. 
3.10.4 RT-PCR 
Total RNA was isolated with the Qiagen RNeasy minikit. Cells (OD600 0.8) were 
harvested from DT medium and treated with RNAprotect bacterial reagent. Harvested cells were 
resuspended in 250 µL of 10 mM Tris (pH 8.5).  The isolation was then performed according to 
the manufacturer’s instructions (without the lysozyme incubation). cDNA was prepared with 
commercially available reverse transcriptase PCR (RT-PCR) kits using 1 µg of RNA and primers 
for all of the S. acidocaldarius TOMM genes.  
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3.10.5 SaciC gene deletion production 
 The pyrEF gene driven by its native promoter and terminator from Sulfolobus 
solfataricus P2 in a pUC19 backbone was graciously supplied by the Whitaker lab (UIUC). 
Homology arms for saciC were inserted upstream and downstream of the PyrEF element.  
Sulfolobus acidocaldarius MR31 competent cells were prepared following the procedure 
described previously. Linearalized plasmid (~1 µg) were transformed into the competent cells by 
electroporation. After electroporation, transformed cells were immediately regenerated in 800 µL 
incubation of DT medium supplemented with uracil. After 1 hour incubation, a portion of the 
cells were plated onto DT plates and a portion were added to 5 mL DT medium and incubated for 
2 weeks prior to plating. Colonies were screened for the loss of saciC using gene specific primers.  
3.10.6 Fosmid library generation 
Genomic DNA for fosmid production was prepared from Sulfolobus acidocaldarius using 
cells grown in 200 mL of DT media to OD600 0.8. Harvested cells were resuspended in 10 mL of 
TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0). 0.5 mL of 10% (w/v) sodium dodecyl sulfate as 
50 µL of proteinase K was added and incubated for 1 h. The resulting lysate was sequencially 
extracted with buffer saturated phenol, chloroform, and isoamyl alcohol (25:24:1) and chloroform 
and isoamly alcohol (24:1). Genomic DNA was precipitated from the aqueous layer by the 
addition of 0.7 volumes isopropanol, and washed twice with 70% (v/v) EtOH, dried and 
resuspended in water.  
 Fosmid construction was performed as previously reported (Eliot, et al. 2008). Psotive 
cloned were screened by PCR for the presence of the Sulfolobus gene cluster using primers for 
the outermost genes and primers for saciA1.  
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3.10.7 Liquid chromatography mass spectrometric comparisons 
Sulfolobus strains (wild type and gene deletion) were grown to OD600 0.8 in DT media. E. 
coli strains (with or without the fosmid) were grown to OD600 1.0 in LB. Harvested cells were 
resuspended in 2 mL of 90% aqueous acetonitrile and agitated for 30s by vortex. After 
centrifugation (14,000 rpm, 5 min) the solution was analyzed by online HPLC (1100 series HPLC 
system; Agilent Technologies) coupled to a QTRAP 2000 mass spectrometer (Applied 
Biosystems). A sample of extract (30 µL) was separated by HPLC using a C18 column with a 
linear gradient of 5% to 95% acetonitrile with 0.1% formic acid in 30 min. MS analysis was 
performed in positive ion mode. Spectrums were then manually curated for differences in masses 
detected. Modification to this method including, varied extraction solvents (acetonitrile, MeOH 
and chloroform at various concentrations), as well as different HPLC gradient times ranging from 
10 -75 minutes were used to try and identify the compounds.  
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3.11 Figures  
 
Figure 3.1 | Representative TOMM clusters and biosynthetic machinery. (A) Genetic 
organization of an example TOMM cluster. The precursor peptide (black) is modified by the 
trimeric BCD complex, consisting of a cyclodehydratase (C, green), dehydrogenase (B, yellow), 
and docking protein (D, blue). (B) Heterocycles are formed on the precursor peptide, converting 
the peptide into a bioactive natural product. Two enzymatic steps occur to modify the precursor 
peptides. First, a water molecule is removed from the peptide as the cyclodehydratase forms 
thiazoline/oxazoline rings. Secondly, a FMN-dependent dehydrogenase removes hydrogen to yield 
the thiazole/oxazole rings. Combined, the reactions lead to a molecular mass loss of 20 Da in the 
peptide (adapted from (Lee 2008)). 
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Figure 3.2 | The TOMM Family Tree. D proteins were used to construct a phylogenetic tree. For 
fused docking proteins, only the docking portion of the protein was used to create the tree. The 
docking proteins cluster based on the function of the precursor peptides they modify. The S. 
acidocaldariusidocaldarius TOMM cluster forms a clade with other TOMMs of unknown function 
(depicted in pink) (adapted from (Melby, et al. 2011)).   
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Figure 3.3 | The S. acidocaldarius TOMM family. A bioinformatics search discovered five 
similar TOMMs. The genetic organization of the clusters is depicted (above). The putative 
functions of the genes are listed in the legend. Note that the S. acidocaldarius and S. islandicus 
clusters contain two precursor peptides, one in the forward and one in the reverse direction. The 
precursor peptides have many potentially heterocyclized residues within the core (below). Blue 
residues indicate heterocyclizable residues. These peptides contain W (underlined) near 
heterocyclizable residues which could be necessary for function.  
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Figure 3.4 | Similarity-identity matrices of related TOMM proteins. In blue are amino acid 
identity scores and in green are amino acid similarity scores, both obtained using ClustalW pairwise 
alignments. Scores were determined by comparing the similar or identical amino acids with the full 
protein sequence after alignment. (A) SaciB, dehydrogenase. (B) SaciC, cyclodehydratase. (C) 
SaciD, docking protein. Abreviation of species are as follows: Saci, Sulfolobus acidocaldarius; 
Sisl, Sulfolobus islandicus REY15A; Rock 3-44, Bacillus cereus Rock3-44; Tmat, 
Thermoanaerobacter mathranii subsp. mathranii str. A3; Aodo, Actinomyces odontolyticus F0309.  
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Figure 3.5 | Heterologous expression of S. acidocaldarius TOMM proteins. S. acidocaldarius 
TOMM biosynthetic proteins tagged with maltose binding protein and expressed in E. coli BL21 
strain. Purified proteins were analyzed by SDS-PAGE and visualized by staining with Coomassie. 
Lane 1: Marker is in kDa. Lane 2-6: SaciA-D. The calculated masses and isolated yields are: MBP-
SaciA1, 50.7 kDa, 6.4 mg/L; MBP-SaciA2, 50.1 kDa, 11.2 mg/L; MBP-SaciB, 71.9 kDa, 6.5 mg/L; 
MBP-SaciC, 73.0 kDa, 48 mg/L; MBP-SaciD, 96.1 kDa, 0.8 mg/L.  
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Figure 3.6 | Alignment with SaciD and RockD. A pairwise alignment of SaciD and RockD 
proteins was created using ClustalW. A Gonnet protein weight matrix was used with a gap opening 
pennalty of 10 and a gap extension penalty of 0.1. Neighbor joining was used for clustering. The 
proteins are 58% similar.   
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Figure 3.7 | MALDI-TOF of unmodified precurosr peptides. MALDI-TOF analysis of the 
unmodified precursor peptides was performed in linear positive mode. The samples were treated 
with Tobacco Etch Virus protease to remove MBP. Leaving the expected weights of SaciA1, 
SaciA2 and RockA to be 5207.9 Da, 4587.4 Da, and 4474.2 Da, respectively. The samples were 
subjected to a Reverse-Phase Zip-Tip procedure using C18 Zip-Tips. The samples were eluted into 
90% acetonitrile with 0.1% trifluoroactic acid. Sinapinic acid was used as the matrix. (A) MALDI-
TOF analysis of SaciA1 unmodified peptide. (B) MALDI-TOF analysis of SaciA2 unmodified 
peptide. (C) MALDI-TOF analysis of RockA unmodified peptide.  
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Figure 3.8 | RT-PCR of S. acidocaldarius TOMM mRNA. Total RNA was isolated from S. 
acidocaldarius grown in DT media in late log-phase. Reverse transcriptase (RT) was added to the 
samples indicated with +. In each case, the amplicons migrate with the anticipated size. All genes 
were verified to be transcribed. The ORF arrow coloring scheme is identical to Fig. 3.1.   
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Figure 3.9 | Gene deletions in S. acidocaldarius. A pyrimidine auxotroph strain has been used to 
generate a deletion mutant. (A) Strain MR31 is a pyrimidine auxotroph with a 18 bp deletion in the 
pyrE gene. This in-frame deletion renders pyrE inactive, but the gene following, pyrF, is still active. 
(B) MR31 cells cannot convert orotate to orotidine monophosphate and therefore cannot produce 
DNA or RNA without the addition of uracil into the media. (C) SaciC was targeted for gene deletion 
using homolgous recombination. A plasmid with a fully synthesized pyrE gene, as well as the 
upstream and downstream elements, is surrounded by the flanking regions of the SaciC gene. The 
pyrE gene was codon optimized to prevent recombination with the natural pyrE gene. Homologous 
recombination led to inactivation of the SaciC gene, and pyrE activity was restored and cells were 
selected by growth without uracil. 
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Abstract 
Natural products remain an important source of drug candidates, but the difficulties 
inherent to traditional isolation, coupled with unacceptably high rates of compound rediscovery, 
limit the pace of natural product detection. Here we describe a reactivity-based screening method 
to rapidly identify exported bacterial metabolites that contain dehydrated amino acids (i.e. 
carbonyl- or imine-activated alkenes), a common motif in several classes of natural products. Our 
strategy entails the use of a commercially available thiol, dithiothreitol, for the covalent labeling 
of activated alkenes by nucleophilic 1,4-addition. Modification is easily discerned by comparing 
mass spectra of reacted and unreacted cell surface extracts. When combined with bioinformatic 
analysis of putative natural product gene clusters, targeted screening and isolation can be 
performed on a prioritized list of strains. Moreover, known compounds are easily dereplicated, 
effectively eliminating superfluous isolation and characterization. As a proof of principle, this 
labeling method was used to identify known natural products belonging to the thiopeptide, 
lanthipeptide, and linaridin classes. Further, upon screening a panel of only 23 actinomycetes, we 
discovered and characterized a novel thiopeptide antibiotic, cyclothiazomycin C. 
4.1 Introduction 
Bacteria have historically been a rich reservoir of architecturally complex natural 
products exhibiting antibiotic activity (Newman, et al. 2012). However, the traditional approach 
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to natural product discovery—bioassay-guided isolation of compounds from extracts—is limited 
by high rates of compound rediscovery (Lewis 2013). As such, the potential value of novel 
natural products to advance the treatment of disease, and in particular to address the issue of 
antibiotic resistance (Fischbach, et al. 2009), warrants the development of alternative strategies to 
discover novel compounds. The advent of widely available genome sequences makes 
bioinformatics-driven methods increasingly appealing, since the enzymatic machinery 
responsible for natural product biosynthesis can be readily identified (Deane, et al. 2013, 
Velásquez, et al. 2011). Consequently, a number of strategies have emerged that aid in 
connecting biosynthetic gene clusters to their products, including selective enzymatic 
derivatization (Gao, et al. 2013), chemoselective enrichment (Odendaal, et al. 2011), mass 
spectrometry-based network analysis (Nguyen, et al. 2013), and PCR prioritization among others. 
Another approach to address the innovation gap in natural product discovery is to utilize the 
intrinsic chemical reactivity of functional groups that are enriched in a target class of metabolites.  
Here, we report the development of a reactivity-based screening method to identify, isolate, 
dereplicate and characterize novel natural products using a combination of bioinformatics and a 
simple chemical probe for modifying a reactive functional group (Figure 4.1).   
The dehydrated amino acids (DHAAs) dehydroalanine and dehydrobutyrine are 
frequently found in natural products (Gersch, et al. 2012), including thiopeptides (Kelly, et al. 
2009), lanthipeptides (Yu, et al. 2013, Zhang, et al. 2012), and linaridins (Claesen, et al. 2010, 
Claesen, et al. 2011, Komiyama, et al. 1993), among others (Figure 4.2). We thus envisioned 
DHAAs serving as a useful chemical handle for the discovery of natural products. It has been 
demonstrated that thiol nucleophiles participate in 1,4-addition into α,β–unsaturated 
carbonyl/imine DHAAs under mild conditions to yield covalent thioether adducts (Figure 4.1A) 
(Bonauer, et al. 2006). This reactivity has been exploited previously in the chemical modification 
of thiostrepton (Myers, et al. 2010, Schoof, et al. 2009, Schoof, et al. 2010), the mapping of 
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Ser/Thr-phosphorylation in proteins (Wells, et al. 2002), the design of solid-phase capture resins 
(Tseng, et al. 2005), and the identification of lanthipeptides (Li, Girard, et al. 2012). Thus, we 
sought to employ this well-established, reliable chemistry as part of a novel tandem 
bioinformatics/reactivity-based screening effort. 
Many classes of DHAA-bearing natural products are ribosomally produced, rendering 
them ideal for genome-guided discovery. The availability of genome sequences has revealed a 
tremendous biosynthetic capability among diverse microbial species (Challis 2008). It has 
become apparent that even well-characterized bacteria harbor the potential to produce an 
abundance of yet-uncharacterized natural products (Bentley, et al. 2002). To overcome the 
burden of rediscovery (Watve, et al. 2001), bioinformatics can be used to preselect bacterial 
strains for screening to only include the organisms with the theoretical capacity to produce a 
particular type of natural product. However, even with the bioinformatics identification of 
promising biosynthetic gene clusters, the detection and isolation of the resultant natural products 
often proves to be difficult given that the products of most biosynthetic pathways are present in 
extremely low quantities (if present at all) during laboratory cultivation. Accordingly, a broadly 
applicable companion strategy to genome mining that would allow the determination of whether a 
natural product of interest is produced at a detectable level would be valuable. We thus reasoned 
that a combination of bioinformatics and reactivity-based screening (i.e. nucleophilic 1,4-addition 
to DHAAs) would streamline natural product discovery efforts. 
4.2 Rationale and Overview of a New Natural Product Discovery Method 
 Herein we have utilized the combination of bioinformatics and nucleophilic 1,4-addition 
chemistry for the rapid labeling, discovery, and dereplication of DHAA-containing natural 
products (Figure 4.1B) by reactivity-based screening. Our discovery pipeline begins with a 
bioinformatic survey for strains of Actinobacteria predicted to be capable of producing a DHAA-
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containing natural product. (Figure 4.1B, Step 1, vide infra for specifics on the bioinformatics-
based strain prioritization). After cultivation, the exported metabolites from the prioritized 
Actinobacteria are extracted with organic solvent using a non-lytic procedure (see Methods). A 
portion of this cell-surface extract then undergoes treatment with dithiothreitol (DTT) in the 
presence of base. DTT was chosen as the thiol probe owing to its low cost and ubiquity in natural 
product discovery laboratories. If reactive DHAA moieties are present in the cell-surface extract, 
the resulting DTT adducts increase the mass of the exported metabolite by multiples of 154.0 Da 
(Figure 4.1B, Step 2). Differential mass spectrometry between the unreacted control and the 
DTT-reacted extracts readily identifies the compounds containing DHAAs within a pre-
determined mass range. The molecular mass, number of DTT additions, and analysis of tandem 
mass spectra, combined with the initial bioinformatic prediction of DHAA-containing natural 
products, permits a rapid determination of compound novelty. At this step, every DTT-labeled 
compound can be analyzed, irrespective of whether the mass corresponds to a predicted 
biosynthetic gene cluster. Known compounds are removed from further analysis at this step, 
leaving only compounds with a high probability of novelty for further structural and functional 
characterization, which is considerably more time-consuming (Figure 4.1B, Step 3). To determine 
if the above proposed discovery pipeline was viable, we sought to discover a novel DHAA-
containing thiopeptide via bioinformatic prioritization and reactivity-based screening utilizing 
nucleophilic 1,4-addition chemistry. 
4.3 Validation of the DTT-Labeling Strategy  
 With the ultimate goal of using the above-described DTT-labeling method to discover a 
new natural product, we first sought to establish an operationally simple route to rapidly screen 
organic extracts for compounds of interest. We utilized two DHAA-containing natural products, 
thiostrepton and geobacillin I, for method development and validation.  
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Thiostrepton, whose biosynthetic gene cluster was identified in 2009 (Kelly, et al. 2009), 
is a thiopeptide produced by Streptomyces azureus ATCC 14921 (among others) (Donovick, et 
al. 1955). Notably, the highly-modified scaffold of thiostrepton contains four DHAAs where 
labeling can occur: three dehydroalanine residues and one dehydrobutyrine (Figure 4.3A) 
(Hensens, et al. 1983). To test the method, reactions were conducted using commercially-
obtained thiostrepton, DTT, and either diisopropylethylamine (DIPEA) or no base at 23 °C for 16 
h in a 1:1 mixture of chloroform and methanol. The authentic thiostrepton standard and the DTT-
reacted samples were then subjected to matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry (MALDI-TOF MS) analysis. The peaks corresponding to unmodified 
thiostrepton (m/z 1664.4 Da) were supplanted in the DTT-reacted sample by peaks corresponding 
to the addition of multiple DTT labels. The tertiary adduct was the most prominent, suggesting 
the successful addition of DTT into the reactive alkenes (Figure 4.4). The addition of DIPEA 
enhanced the DTT-labeling reaction. Other bases, including triethylamine and 1,8-
diazabicycloundec-7-ene (DBU), were tested and labeling occurred similarly to the reactions 
using DIPEA. A range of DIPEA concentrations were tested (10–50 mM) and the extent of 
labeling did not greatly vary. Therefore all further experiments employed 10 mM DIPEA. 
To confirm DTT-labeling of thiostrepton could be observed by MALDI-TOF MS in the 
context of a more complex biological mixture, we subjected an organic cell-surface extract of S. 
azureus ATCC 14921 (thiostrepton producer) to the above labeling reaction. Analogous to the 
pure thiostrepton sample, comparison of the crude extract with the DTT-labeled extraction again 
showed the appearance of multiple DTT adducts, this time with the tetra-adduct being the 
primary species; a higher extent of labeling was seen here due to the larger relative excess of the 
labeling reagents in the context of a biological extract (Figure 4.3B). Although thiostrepton 
contains only 4 reactive DHAA sites, a minor 5th adduct was observed in both the commercially 
available and extracted samples, presumably from reaction with another electrophilic site. 
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Thiostrepton possesses an additional alkene that is conjugated to pyridine within the quinaldic 
acid moiety; we hypothesize that addition of DTT may have occurred at this site, given the 
literature precedent for addition of thiols to aromatic-conjugated alkenes (Ranu, et al. 2007). 
Importantly, the appearance of this low-intensity ion does not complicate detection or 
interpretation of the labeled analyte. 
Lanthipeptides are ribosomally synthesized and post-translationally modified peptide 
natural products (RiPPs) that are easily identified using bioinformatics and frequently contain 
DHAAs (Arnison, et al. 2013, Velásquez, et al. 2011, Yu, et al. 2013, Zhang, et al. 2012). To test 
if the reactivity-based screening method could also be used to identify other classes of natural 
products in varied bacterial extracts, we attempted to label the lanthipeptide geobacillin I. 
Geobacillin I, a nisin analogue, is produced by Geobacillus sp. M10EXG (Figure 4.5A) (Garg, et 
al. 2013, Garg, et al. 2012). Upon subjecting an organic cell-surface extract from Geobacillus sp. 
M10EXG to our labeling conditions, a mass corresponding to 2 DTT adducts was prominently 
observed; a third adduct was visible but of very low intensity (Figure 4.5B). Only two reactive 
DHAA sites are present in geobacillin I: a dehydroalanine and a dehydrobutyrine. However, 
transient DHAA sites occur in the biosynthesis of the lanthionine rings, which are formed by 
intramolecular 1,4-addition of cysteines to DHAAs (Yu, et al. 2013). We hypothesize, 
accordingly, that a small percentage of the geobacillin present in the extract may have an 
unformed lanthionine ring, leaving a free reactive site available for DTT-labeling. Again, even 
under stoichiometrically forcing conditions, this extract adduct was of only minor abundance and 
thus did not interfere with compound detection or analysis.  
4.4 Bioinformatics Guided Strain Prioritization  
Like lanthipeptides, thiopeptides are RiPPs and the biosynthetic genes responsible for 
their production are often clustered, rendering them identifiable by sequence similarity searching. 
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From the perspective of the present study, we sought to prioritize bacterial strains for subsequent 
screening based on the presence of biosynthetic genes capable of installing DHAAs (often 
misleadingly annotated as “lantibiotic dehydratases”) (Zhang, et al. 2012). These genes, however, 
can be found in a variety of other natural product gene clusters and not exclusively in thiopeptide 
clusters. Therefore, we first identified clusters that encode for the YcaO cyclodehydratase protein 
that is necessary for the biosynthesis of all thiazole/oxazole-modified microcin natural products, 
of which thiopeptides can be broadly categorized. Strains containing a YcaO cyclodehydratase 
were analyzed further for the local co-occurrence of genes encoding a “lantibiotic dehydratase” 
(for the production of DHAAs) and a thiopeptide-like precursor peptide (Figure 4.6A) (Li, Qu, et 
al. 2012). 130 unique strains of recently sequenced (in-house) Actinobacteria from the Northern 
Regional Research Laboratory collection (NRRL), which is curated by the Agricultural Research 
Service under the supervision of the U.S. Department of Agriculture (USDA/ARS), were 
predicted to have the genetic capacity to produce a DHAA-containing thiopeptide (Figure 4.1B). 
The precursor peptide sequences from these clusters were then used to estimate the masses of the 
final natural products for dereplication and characterization purposes (Figure 4.6B). These strains 
were then subjected to reactivity-based screening with DTT and DIPEA to discover a novel 
thiopeptide. 
4.5 MS-Based Screening of Prioritized Strains  
 Twenty-three of the prioritized strains with novel precursor peptide sequences were 
selected for screening by DTT-labeling (Figure 4.7). We first noticed a sample containing 1–2 
DTT adducts on an exported metabolite with a mass of [M+H]+, m/z 1855.0 Da. While we were 
intentionally blind to which of the Actinobacteria strains were undergoing analysis, after labeling 
we established that this particular extract originated from Streptomyces griseus subsp. griseus, 
and the labeled mass did not correlate with the expected mass of the predicted thiopeptide from 
this strain. However, Streptomyces griseus subsp. griseus is a known producer of grisemycin, of 
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which the mass of the labeled natural product did correlate (Figure 4.8A-B). MS/MS 
fragmentation analysis yielded a seven amino acid sequence tag confirming the identity of the 
compound as grisemycin (Figure 4.8C) (Claesen, et al. 2011). The labeling and identification of 
grisemycin, a member of the linaridin class of natural products, further validated our reactivity-
based screen while also highlighting the usefulness of bioinformatic integration to rapidly 
dereplicate known compounds. 
The organic cell-surface extract from a separate sample contained a compound ([M+H]+, 
m/z 1486.3 Da) that underwent labeling to contain primarily three DTT adducts (Figure 4.9A). 
This mass correlated well with the predicted mass of a hypothetical thiopeptide from NRRL strain 
WC-3908. The thiopeptide gene cluster from WC-3908 was similar to the gene clusters 
responsible for the production of the thiopeptides cyclothiazomycin A, originally termed 5102-I 
(Wang, et al. 2010), and cyclothiazomycin B (Figure 4.9B). The core region of the precursor 
peptide (i.e. the portion that undergoes enzymatic tailoring to yield the mature natural product) 
(Arnison, et al. 2013, Melby, et al. 2011) from WC-3908 differed by two amino acids from the 
precursor peptides of cyclothiazomycin A and B (Figure 4.9C). Accordingly, we designated the 
WC-3908 thiopeptide cyclothiazomycin C. Given that the structures of cyclothiazomycin A and 
B have been reported (Aoki, Ohtsuka, Itezono, et al. 1991, Aoki, Ohtsuka, Yamada, et al. 1991, 
Hashimoto, et al. 2006), we could accurately predict the structure of cyclothiazomycin C, which 
was in agreement with the labeling results (Figure 4.9D). 
4.6 Verification of the Cyclothiazomycin C Structure  
 Prior to detailed structural characterization, cyclothiazomycin C was purified by MPLC 
and HPLC (Figure 4.10). The mass spectrum of purified cyclothiazomycin C revealed an [M+H]+ 
ion of m/z 1486.3309 Da (Figure 4.11A), supporting the molecular formula for the predicted 
structure of cyclothiazomycin C (C60H67N19O13S7). Analysis of the collision-induced dissociation 
(CID) mass spectrum corroborated the amino acid sequence of the precursor peptide, strongly 
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connecting the predicted gene cluster to the mature natural product (Figure 4.11B). NMR 
spectroscopy was then used to confirm the predicted structure of cyclothiazomycin C 
(Supplemental Figures 7–8). Bond connectivity was established using 1H-1H COSY, 1H-1H 
TOCSY, 1H-13C HSQC, and 1H-13C HMBC experiments. Chemical shifts were assigned from this 
information and by comparison to the reported values for cyclothiazomycin B (Hashimoto, et al. 
2006). Due to the spectral similarity to cyclothiazomycin B, we have assigned the 
stereochemistry of cyclothiazomycin C analogously to the reported compound.  
4.7 Conservation Analysis of the Cyclothiazomycin C Biosynthetic Gene Cluster 
To provide additional evidence that the thiopeptide gene cluster from WC-3908 was 
responsible for the production of cyclothiazomycin C, conservation analysis was performed with 
the cyclothiazomycin A, B, and C (putative) gene clusters. The cyclothiazomycin A biosynthetic 
genes derived from Streptomyces hygroscopicus subsp. jinggangensis 5008 while the 
cyclothiazomycin B genes were from Streptomyces mobaraensis. A subset of the genes predicted 
for the production of cyclothiazomycin B (Wang, et al. 2010) was conserved among the three 
clusters (Figure 4.9B). All three clusters contain a short open reading frame, here designated 
ctmA, encoding the precursor peptide. CtmD encodes a “fused” TOMM cyclodehydratase (E1 
ubiquitin-activating enzyme/MccB-like and YcaO domains), which implicates CtmD in the 
formation of thiazolines (Dunbar, et al. 2012, Dunbar, et al. 2013). CtmB encodes a flavin 
mononucleotide-dependent protein, putatively responsible for the dehydrogenation of the 
thiazolines to thiazoles (Zhang, et al. 2014). CtmE and ctmF encode homologs of a split 
lanthipeptide dehydratase, which performs the dehydration of serine and threonine to 
dehydroalanine and dehydrobutyrine (Yu, et al. 2013, Zhang, et al. 2012). Like all thiopeptides, 
cyclothiazomycin C has a substituted 6-membered, nitrogen-containing central heterocycle (here 
a pyridine). In the case of cyclothiazomycins A and B, the pyridine moiety is likely formed by the 
gene product of ctmG, given the homology to tclM, which has been implicated in the formal 
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[4+2] cycloaddition reaction during thiocillin biosynthesis (Figure 4.12) (Bowers, et al. 2010). 
For cyclothiazomycin C, a gene with high similarity to ctmG from the cyclothiazomycin A and B 
clusters is present, but distantly located in the genome, indicating that the cyclothiazomycin C 
gene cluster is fragmented. Interestingly, ctmG from WC-3908 is found directly next to a gene 
duplication of ctmF, which is suggestive of paralogous duplication (Figure 4.12). CtmI, which is 
present in all three clusters, encodes a ThiF-like protein. ThiF-like proteins have been implicated 
in the biosynthesis of thiamine diphosphate in E. coli. However, the function of ThiF-like 
proteins in the context of TOMM biosynthesis remains to be established. Other local genes 
include ctmH, which is a LuxR-type regulatory gene and ctmJK, which are omitted from the 
cyclothiazomycin A and C clusters and have no known function (Figure 5).We further note that 
the genes flanking the conserved region are highly disparate between the three clusters (Figure 
4.13). This subset of genes, ctmA-G and ctmI from Streptomyces hygroscopicus subsp. 
jinggangensis 5008 were recently shown to be regulated by the LuxR-type regulatory gene ctmH. 
Furthermore, the deletion of ctmA, ctmD, ctmF, and ctmG abolished the production of 
cyclothiazomycin A (Zhang, et al. 2014). These data further support the gene cluster prediction 
for cyclothiazomycin C from WC-3908. 
4.8 Assessment of Cyclothiazomycin Bioactivity  
Previous reports on cyclothiazomycins A and B describe a wide range of bioactivities, 
including renin inhibition (Aoki, Ohtsuka, Yamada, et al. 1991), RNA polymerase inhibition 
(Hashimoto, et al. 2006), and antifungal activity (Mizuhara, et al. 2011). We found that purified 
cyclothiazomycin C exhibited growth inhibitory action toward several Gram-positive 
(Firmicutes) bacteria but was inactive against all tested Gram-negative (Proteobacteria) 
organisms (Table 1). The greatest inhibitory activity was observed towards the genus Bacillus. 
Based on prior reports, we decided to also evaluate if cyclothiazomycin C exhibited growth 
inhibitory action toward a variety of fungal strains, but none was observed.  
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To further clarify cyclothiazomycin bioactivity, we obtained a cyclothiazomycin B 
producer, strain NRRL B-3306, and purified cyclothiazomycin B in a manner analogous to that 
employed for cyclothiazomycin C (Figures 4.14-4.15). As above, we assessed cyclothiazomycin 
B for antibiotic and antifungal activity. Cyclothiazomycin B also had the greatest inhibitory 
activity towards the genus Bacillus, with little to no activity against a panel of Gram-negatives 
and fungal strains (Table 4.1). This activity does not align with previous reports (Hashimoto, et 
al. 2006, Mizuhara, et al. 2011); however, additional fungal strains will need to be tested to more 
concretely establish cyclothiazomycin spectrum of activity. The antibiotic activity of 
cyclothiazomycin B and C are similar to known thiopeptides, which act as translation inhibitors 
by binding to either the 50S subunit or EF-Tu (Just-Baringo, et al. 2014). It is possible that the 
cyclothiazomycins act in a similar manner but the determination of the precise mode of action 
will require further exploration. 
4.9 Summary and Outlook  
In summary, we have described a reactivity-based screening method to conveniently 
identify natural products containing dehydrated amino acids (DHAAs). This method employs 
ubiquitous reagents and instrumentation, making it a broadly accessible strategy for natural 
product discovery. Three characteristics make the nucleophilic 1,4-addition labeling procedure 
operationally straightforward: (a) anhydrous solvents are unnecessary, meaning the reaction is 
performed under ambient atmosphere; (b) the reagents employed are common in most 
laboratories and easily handled; and (c) the large excess of labeling reagent relative to the 
substrate means that precise stoichiometric calculations for each reaction are unnecessary. 
Although under these excess labeling conditions we often observe minor peaks related to non-
DHAA labeling, these species never convoluted spectral interpretation. Including a rapidly 
dereplicated example, we validated the use of nucleophilic 1,4-additions for natural product 
discovery with the labeling of three previously characterized natural products: thiostrepton, 
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grisemycin, and geobacillin I. This reactivity based screen was combined with bioinformatics to 
increase the rate of discovery, even with low abundance products. Often, natural products are 
present only at trace quantities. By capitalizing on the remarkable sensitivity of mass 
spectrometry, the compound(s) to be discovered do not need to be present at bioactive 
concentrations, they only need to be detectable upon labeling. After screening the organic extracts 
of only 23 Actinobacteria, we report on a new thiopeptide, cyclothiazomycin C. The structure of 
cyclothiazomycin C was established through MS and NMR, along with confirmed bioactivity 
towards Gram-positive bacteria. When compared to traditional bioassay-guided isolation, which 
can require many thousands of samples to be screened to find new compounds, our discovery rate 
(1 out of 23 strains) highlights the potential of this tandem strategy. With the substantial rise of 
available genomic sequences, we anticipate that the combination of bioinformatics and simple 
chemoselective reactivity-based labeling will provide a powerful tool to identify novel natural 
products, while dramatically reducing the time invested on the unfruitful rediscovery of known 
compounds. 
4.10 Experimental 
4.10.1 Preparation of cell extracts for screening 
Actinomycete strains were grown in 10 mL of MS medium (1 L contains 20 g mannitol, 
20 g roasted soy flour) at 30 °C for 7 d. Exported metabolites were extracted from the cultures 
using 2 mL of n-BuOH at room temperature. For thiostrepton production, Streptomyces azureus 
was grown in 10 mL of ISP4 medium (1 L contains 10 g soluble starch, 1 g K2HPO4, 1 g MgSO4, 
1 g NaCl, 2 g Na2SO4, 2 g CaCO3, 1 mg FeSO4, 1 mg ZnSO4 heptahydrate, 1 mg MnCl2 
heptahydrate) for 7 d at 30 °C. Thiostrepton was extracted with 1 mL of CHCl3 at 23 °C. Both 
extracts were agitated for 1 min by vortex, submitted to centrifugation (4000 × g, 5 min), and the 
organic layer was removed from the intact, harvested cells. For geobacillin I production, 
Geobacillus sp. M10EXG was grown on modified LB agar (1 L contains 10 g casein enzymatic 
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hydrolysate, 5 g yeast extract, 5 g NaCl and 10 g agar) at 50 °C for 60 h. Cells were removed 
from the plates with 10 mL of 70% aq. i-PrOH and agitated by rocking for 24 h at 23 °C. The 
intact cells were then removed from the extract by centrifugation (4000 × g, 5 min). An aliquot (1 
µL) of the extract was then mixed with 9 µL of sat. α-cyano-4-hydroxycinnamic acid (CHCA) 
matrix solution in 1:1 MeCN/H2O containing 0.1% trifluoroacetic acid (TFA). 1 µL was spotted 
onto a MALDI plate for subsequent MALDI-TOF MS analysis. 
4.10.2 DTT-labeling  
For commercially-obtained thiostrepton (Calbiochem, 99%), a 20 μL volume of 10.5 mM 
thiostrepton, 500 mM DTT, and 10 mM DIPEA in 1:1 CHCl3/MeOH was allowed to react at 23 
°C for 16 h. For the no base reaction, thiostrepton and DTT were added similarly to above and 
MeOH (without DIPEA) was added to establish a 1:1 CHCl3/MeOH.  The sample was then 
analyzed for DTT incorporation by MALDI-TOF MS (see below). For thiostrepton produced by 
Streptomyces azureus (and thus labeling occurred in the context of the crude cell-surface extract), 
14 μL of the extract was mixed with DTT (in MeOH) and DIPEA (in MeOH) to generate a final 
volume of 20 μL with a final concentration of 500 mM DTT and 10 mM DIPEA, in 7:3 
CHCl3/MeOH and the mixture was allowed to proceed for 16 h at 23 °C. An aliquot (1 µL) of the 
extract was then mixed with 9 µL of sat. α-cyano-4-hydroxycinnamic acid (CHCA) matrix 
solution in 1:1 MeCN/H2O containing 0.1% TFA. 1 µL was spotted onto a MALDI plate for 
subsequent MALDI-TOF MS analysis.  
4.10.3 Bioinformatics based strain prioritization  
A previously reported profile Hidden Markov Model and the program HMMER were 
used to identify the YcaO cyclodehydratase (Pfam PF02624) (Doroghazi, et al. 2013). The local 
genomic region (10 open reading frames on either side of the YcaO gene) was analyzed manually 
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for the presence of a “lantibiotic dehydratase” gene and a putative precursor peptide. Only strains 
with the presence of all three genes were taken forward for reactivity-based screening.  
4.10.4 MALDI-TOF mass spectrometric analysis 
MALDI-TOF mass spectrometry was performed using a Bruker Daltonics 
UltrafleXtreme MALDI-TOF/TOF instrument operating in positive reflector mode. The 
instrument was calibrated before data acquisition using a commercial peptide calibration kit 
(AnaSpec – Peptide Mass Standard Kit). Analysis was carried out with Bruker Daltonics 
flexAnalysis software. All spectra were processed by smoothing and baseline subtraction.   
4.10.5 Isolation of cyclothiazomycin C 
WC-3908 was grown in 10 mL of ATCC 172 medium at 30 °C for 48 h. 300 μL of the 
culture was spread onto 15 cm plates (ca. 75 mL of solid ATCC medium). The plates were then 
incubated for 7 d at 23 °C. A razor blade was used to remove the bacterial lawn from the solid 
medium. The bacterial growth from 14 plates (~1 L of medium) was extracted with n-BuOH (500 
mL) for 24 h at 23 °C. The extract was then filtered through Whatman filter paper and allowed to 
evaporate under nitrogen before being redissolved in 3:1 pyridine:water (ca. 3 mL) and 
transferred to a 50 mL conical tube. The resulting solution was clarified by centrifugation, to 
remove insoluble debris (4000 × g, 5 min). The supernatant was then injected onto a reverse-
phase C18 silica column (TeleDyne Isco 5.5 g C18 Gold cartridge) and purified by MPLC 
(gradient elution from 20-95% MeOH/10 mM aq. NH4HCO3). Fractions containing the desired 
product (as determined by MALDI-TOF MS; [M+H] m/z = 1486) were combined and 
immediately concentrated by rotary evaporation. The resulting residue was dissolved in 3:1 
pyridine/water (ca. 0.5 mL), transferred to a microcentrifuge tube, centrifuged (15000 × g, 5 
min), filtered (0.2 µm polyethersulfone syringe filter), and further purified by HPLC. Semi-
preparative HPLC employed a Thermo Scientific Betasil C18 column (100 Å; 250  10 mm; 5 
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µm particle size) operating at 4.0 mL min-1 on a PerkinElmer Flexar LC system using Flexar 
Manager software. Solvent A was 10 mM aq. NH4HCO3. Solvent B was MeOH. 
Cyclothiazomycin C was purified by isocratic elution at 72% B, typically eluting 19.5 min after 
initiation of the HPLC run (alternatively, the elution time was ~12 min when 75% B was used). 
HPLC progress was monitored by photodiode array (PDA) UV-Vis detection. Fractions 
corresponding to the desired product (as determined by UV-Vis and MALDI-TOF MS) were 
immediately concentrated under rotary evaporation or under a stream of N2 gas. The resulting 
residue was suspended in water (ca. 1 mL), assisted by vortex mixing and sonication. The 
suspended product was flash-frozen in liquid N2 and lyophilized for >24 h to give purified 
cyclothiazomycin C as a white to off-white powder. Purity was determined by analytical HPLC 
[Thermo Scientific Betasil C18 column (100 Å; 250  4.6 mm; 5 µm particle size) operating at 
1.0 mL min-1 using the same solvents] and NMR. Isolated yield ranged from 10-90 μg/plate (15 
cm diameter). 
4.10.6 Isolation of cyclothiazomycin B 
NRRL strain B-3306 was grown in a fashion identical isolation conditions for WC-3908. 
Cyclothiazomycin B ([M+H] m/z = 1528) was also purified in the same manner as 
cyclothiazomycin C, except that HPLC purification employed 75% B (retention time typically ca. 
17 min). After lyophilization, an off-white powder was obtained. Purity was determined by 
analytical HPLC [Thermo Scientific Betasil C18 column (100 Å; 250  4.6 mm; 5 m particle 
size) operating at 1.0 mL min-1 using the same solvents]; identity was determined by high-
resolution mass spectrometry. Isolated yield was approximately 13 µg/plate (15 cm diameter). 
4.10.7 FT-MS/MS analysis of cyclothiazomycin B and C  
The purified cyclothiazomycins were dissolved in 80% aq. MeCN with 0.1% formic acid. 
Samples were directly infused using a 25 μL Hamilton gas-tight syringe (cyclothiazomycin C) or 
113 
 
an Advion Nanomate 100 (cyclothiazomycin B), into a ThermoFisher Scientific LTQ-FT hybrid 
linear ion trap, operating at 11T (calibrated weekly). The FT-MS was operated using the 
following parameters: minimum target signal counts, 5,000; resolution, 100,000; m/z range 
detected, dependent on target m/z; isolation width (MS/MS), 5 m/z; normalized collision energy 
(MS/MS), 35; activation q value (MS/MS), 0.4; activation time (MS/MS), 30 ms. Data analysis 
was conducted using the Qualbrowser application of Xcalibur software (Thermo-Fisher 
Scientific). 
4.10.8 NMR spectroscopy of cyclothiazomycin C  
NMR spectra were recorded on a Varian NMR System 750 MHz narrow bore magnet 
spectrometer (VNS750NB employing a 5 mm Varian 1H[13C/15N] PFG X, Y, Z probe) or a 
Varian Unity Inova 500 MHz narrow bore magnet spectrometer (UI500NB employing a 5 mm 
Varian 1H[13C/15N] PFG Z probe). Spectrometers were operated at 750 MHz and 500 MHz, 
respectively, for 1H detection, and 188 MHz for indirect 13C detection. Carbon resonances were 
assigned via indirect detection (HSQC and HMBC experiments). Resonances were referenced 
internally to the most downfield solvent peak (8.74 ppm, pyridine). Default Varian pulse 
sequences were employed for 1H, COSY, DQF-COSY, TOCSY, HSQC, HMBC, and ROESY 
experiments. Samples were prepared by dissolving approximately 3-7 mg of cyclothiazomycin C 
(HPLC-purified and lyophilized) in pyridine-d5/D2O (3:1, 600 µL). Pyridine-d5 (99.94% D) and 
D2O (99.9% D) were obtained from Cambridge Isotope Laboratories (Andover, MA). Samples 
were held at 25 °C during acquisition.  
4.10.9 Analysis of NMR data  
Assigned resonances are shown in tabular form and directly on the structure within 
Supplemental Figure 7. Due to the solvent employed (3:1 pyridine-d5/D2O), exchangeable peaks 
(i.e. N-H, O-H) were not detected. The corresponding 1H resonances of the analogous locations in 
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cyclothiazomycin B1 (reported previously (Hashimoto, et al. 2006)) are also given in 
Supplemental Figure 7 for comparison. Resonances were assigned by 2D NMR spectroscopy, as 
well as by comparison to the reported spectra of cyclothiazomycin B1 (Hashimoto, et al. 2006). 
4.10.10 Evaluation of cyclothiazomycin B and C antibiotic activity 
Bacillus subtilis strain 168, Bacillus anthracis strain Sterne, E. coli MC4100, and 
Pseudomonas putida KT2440 were grown to stationary phase in 10 mL of Luria-Bertani broth 
(LB) at 37 °C. Staphylococcus aureus USA300 (methicillin-resistant), Enterococcus faecalis 
U503 (vancomycin-resistant), and Listeria monocytogenes strain 4b F2365 were grown to 
stationary phase in 10 mL brain-heart infusion (BHI) medium at 37 °C. Neisseria sicca ATCC 
29256 was grown to stationary phase in 5 mL of gonococcal broth at 37 °C. The cultures were 
adjusted to an OD600 of 0.013 in the designated medium before being added to 96-well 
microplates. Successive two-fold dilutions of cyclothiazomycin C or cyclothiazomycin B 
(standard solution: 5 mg mL-1 in DMSO) were added to the cultures (0.5–64 μg mL-1). As a 
control, kanamycin was added to samples of E. coli, B. subtilis, B. anthracis, P. putida, L. 
monocytogenes, and N. sicca with dilutions from 1–32 μg mL-1. Gentamycin was used as a 
control for S. aureus and E. faecalis. As a negative control, an equal volume of DMSO lacking 
antibiotic was used. Plates were covered and incubated at 37 °C for 12 h with shaking. The 
minimum inhibitory concentration (MIC) reported is the value that suppressed all visible growth.  
4.10.11 Evaluation of cyclothiazomycin B and C antifungal activity  
Saccharomyces cerevisiae, Talaromyces stipitatus, and Aspergillus niger were grown for 
36 h in 2 mL of YPD medium (1 L contains 10 g yeast extract, 20 g Peptone and 20 g Dextrose) 
at 30 °C. Fusarium virguliforme was grown for 7 d on potato dextrose agar at 30 °C. Spores were 
isolated and a suspension of 106 spores in potato dextrose broth was added to the 96-well 
microplate. S. cerevisiae cultures were adjusted to an OD600 of 0.013 in the designated medium 
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before being added to 96-well microplates. T. stipitatus, and A. niger were not diluted prior to 
adding to the 96-well microplate.  Successive two-fold dilutions of cyclothiazomycin C and 
cyclothiazomycin B (standard solution: 5 mg mL-1 in DMSO) were added to the cultures (0.5–64 
μg mL-1). As a positive control, amphotericin B was added to the cultures with dilutions from 0.5-
8 μg mL-1. An equal volume of DMSO was used as a negative control. Plates were covered and 
incubated at 30 °C for 36 h for T. stipitatus, A. niger, and S. cerevisiae or 60 h for F. virguliforme 
with shaking. The minimum inhibitory concentration (MIC) reported is the value that suppressed 
all visible growth.   
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4.11 Figures and Tables 
 
 
Figure 4.1 | Strategy for natural product discovery by bioinformatics prioritization and 
nucleophilic 1,4-addition chemistry. (A) Reaction scheme for the thiol (DTT/DIPEA) labeling 
method with 1,4-addition sites indicated with yellow circles. (B) Work flow for the bioinformatics-
based strain prioritization, subsequent DTT-labeling, and MS screening (reactivity-based 
screening). (1) Prediction of DHAA-containing thiopeptide biosynthetic gene clusters from 400 in-
house sequenced genomes (all from the USDA ARS Actinobacteria collection, which totals ~9000 
unique strains). More information on strain prioritization is given in Supplemental Figure 3. (2) 
DHAAs on exported bacterial metabolites that are reactive towards nucleophilic 1,4-additions (by 
DTT/DIPEA) are identified by differential mass spectrometry. (3) Compound isolation and 
characterization after dereplication. Compounds are dereplicated, taking only potentially novel 
compounds through the time-consuming characterization steps. Of the 400 sequenced genomes, 
130 strains were prioritized, 23 strains were screened, 1 compound was rapidly dereplicated, and 1 
compound was predicted to be novel and thus further characterized.  
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Figure 4.2 | Representative natural products bearing dehydrated amino acids (DHAAs). 
Structures of example molecules that contain DHAAs suitable for nucleophilic addition are shown. 
The sites of potential nucleophilic reactivity (i.e. the DHAA alkenes, often in the form of an α,β-
unsaturated carbonyl) are indicated with yellow circles. LAP, linear azol(in)e-containing peptide.  
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Figure 4.3 | DTT-labeling of thiostrepton as a proof of principle. (A) Structure of thiostrepton 
with DHAAs suitable for nucleophilic addition highlighted with yellow circles (B) MALDI-TOF 
MS of thiostrepton labeling performed in the context of an organic, cell-surface extract of 
Streptomyces azureus ATCC 14921. The black spectrum (top) is an unreacted control while the red 
spectrum (bottom) resulted from DTT-labeling. Thiostrepton was visibly labeled by 1-5 DTT 
moieties, with the 4 DTT adduct being the majority product.   
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Figure 4.4 | Base-dependence of the DTT-labeling reaction. MALDI-TOF MS of pure 
(commercially-obtained) thiostrepton reacted with DTT in the presence of diisopropylethylamine 
(DIPEA) (top), or no base (bottom). Thiostrepton was visibly labeled with 1-5 DTT moieties. * 
denotes peaks not corresponding to DTT labeling. 
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Figure 4.5 | DTT-labeling of geobacillin I in a cell-surface extract. (A) Structure of geobacillin 
I. Dha, dehydroalanine; Dhb, dehydrobutyrine; Ala-S-Ala, lanthionine; Abu-S-Ala, β-methyl-
lanthionine. (B) Nucleophilic labeling with DTT of geobacillin I within the context of the organic 
extract of Geobacillus sp. M10EXG. Mass spectra of crude unlabeled extract (black spectrum, top) 
and DTT-labeled material (red spectrum, bottom) are shown. Extent of labeling with DTT is 
indicated on the bottom spectrum (2 DTT adducts are clearly observed, with the third being a very 
low intensity ion).    
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Figure 4.6 | Bioinformatic prioritization of strains. (A) Bioinformatics prioritization schematic. 
1) A list is populated with strains encoding a thiazole/oxazole-modified microcin (TOMM) 
cyclodehydratase “YcaO” necessary for the heterocyclization of select Cys, Ser, and Thr, residues. 
2) The list of strains is then trimmed to only contain strains that also harbor a “lantibiotic” 
dehydratase in close proximity (within 10 open reading frames on either side) to the YcaO protien. 
3) TOMM-like precursor peptides from the trimmed list are then identified, and the mass of the 
final natural product is predicted for use in the dereplication process. (4) If strains make it through 
steps 1-3, reactivity-based screening with DTT is utilized to identify natural products of interest. 
(B) Predicted core regions of the precursor peptides identified in the 23 strains prioritized and 
screened using the DTT labeling method. Highlighted in red are the precursor peptides predicted 
from WC-3908 (the producer of cyclothiazomycin C) and WC-3480 (the producer of grisemycin).  
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Figure 4.7  
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Figure 4.7 (continued) 
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Figure 4.7 (continued) 
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Figure 4.7 (continued) | Mass spectra of strains screened by the DTT labeling method. Mass 
spectrometry data (m/z 900 – 4200 Da) is shown for all strains screened except Streptomyces 
griseus subsp. griseus and WC-3908 (shown as figures 4 and 5 in the main text, respectively). The 
mass spectra of the unreacted organic cell-surface extracts are shown in black with the 
corresponding DTT-reacted extracts in red. Each spectrum is labeled according to the strain 
designation (NRRL identifier) and whether or not DTT/DIPEA was added. NRRL, Northern 
Regional Research Laboratory collection, which is curated by the Agricultural Research Service 
under the supervision of the U.S. Department of Agriculture (USDA/ARS).  
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Figure 4.8 | Grisemycin DTT-labeling and dereplication. (A) Structure of grisemycin. Dhb, 
Dehydrobutyrine. (B) MALDI-TOF MS analysis of unreacted grisemycin (black spectrum, top) 
and DTT-labeled grisemycin (red spectrum, bottom) from an organic, cell-surface extract showing 
1-2 DTT adducts. (C) MS/MS analysis of grisemycin with the discerned sequence tag listed above 
the spectrum. 
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Figure 4.9 | Identification, genetics, and structure of cyclothiazomycin C. (A) MALDI-TOF 
MS analysis showing spectra of unreacted (black spectrum, top) and DTT-labeled (red spectrum, 
bottom) extracts of WC-3908, the producer of cyclothiazomycin C. *, peaks do not correspond to 
DTT-labeled cyclothiazomycin C. (B) Conserved open-reading frames from each of the three 
cyclothiazomycin gene clusters (precise cluster boundaries are not yet established). Genes are 
color-coded with proposed functions given in the legend. The strain used for the comparison of 
cyclothiazomycin A is Streptomyces hygroscopicus subsp. jinggangensis 5008 and 
cyclothiazomycin B is Streptomyces mobaraensis. (C) Precursor peptide sequences of 
cyclothiazomycins A, B, and C. Highlighted in red are residues that differ in the core region of the 
peptide. The asterisk denotes the leader peptide cleavage site. (D) Structures of cyclothiazomycins 
A, B, and C. 
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Figure 4.10 | HPLC trace and UV spectrum of cyclothiazomycin C. (A) A sample (spatula tip) 
of purified cyclothiazomycin C was dissolved in 50% MeOH (B)/aq. 10 mM NH4HCO3 (A) (100 
µL). An aliquot (20 µL) was analyzed by HPLC (isocratic 72% B for 35 min). Photodiode array 
(PDA) detection was used to monitor absorbance (abs) from 190-400 nm. A blank injection was 
also run and subtracted from the cyclothiazomycin C chromatogram; the resulting spectrum with 
UV monitoring at 254 nm is shown. (B) Cyclothiazomycin C exhibits UV absorbance consistent 
with that reported for cyclothiazomycin A and B1/B2 (Aoki, Ohtsuka, Yamada, et al. 1991, 
Hashimoto, et al. 2006). A UV spectrum (PDA) from the HPLC trace at 19.5 min is shown (sh, 
shoulder).  
129 
 
 
 
Figure 4.11 | High resolution Fourier transform mass spectrometry (FT-MS) analysis of 
cyclothiazomycin C. (A) The m/z scan of purified cyclothiazomycin C showed an ion in the 1+ 
charge state with an observed isotopic m/z value with < 2 ppm error from the calculated value for 
cyclothiazomycin C. (B) CID spectrum of m/z 1486. The monoisotopic mass values are given for 
assigned peak predictions. The number ranges given below the mass values refer to a shorthand 
notation describing predicted fragments of cyclothiazomycin C. A key for the shorthand notation 
for the structure of cyclothiazomycin C is given in pictorial format using single letter codes for the 
amino acids, the residue’s N to C position, and lines depicting molecular connectivity within the 
mature structure. The colors used for the shorthand notation depict the modification present at a 
particular residue. Purple, thiazoline moieties; green, thioether linkage; cyan, thiazole moieties; 
red, dehydrated amino acids; orange, pyridine moiety; black, unmodified amino acids. 
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Figure 4.12 | Amino acid similarity for CtmG, the putative formal [4+2] cycloaddition protein. 
(A) The cyclothiazomycin C biosynthetic gene cluster (strain WC-3908, NCBI accession 
KJ651958 apparently lacked the ctmG gene for the carrying out the [4+2] cycloaddition required 
for pyridine formation (Figure 4.9B). However, BLAST searching found a highly similar gene 
elsewhere on the WC-3908 chromosome (NCBI accession KJ690935). Interestingly, ctmG from 
WC-3908 is adjacent to ctmF, which appears to have been duplicated from the rest of the 
cyclothiazomycin C biosynthetic gene cluster (Figure 5). (B) Amino acid alignment of the CtmG 
proteins from the cyclothiazomycin A (S. hygroscopicus), cyclothiazomycin B (S. mobaraensis), 
and cyclothiazomycin C (WC-3908) biosynthetic gene clusters. Below the aligned residues, * 
represents identical residues, while : and . represent highly and moderately similar residues, 
respectively. (C) Sequence similarity (sum of identical and similar residues / length of longest 
protein) and identity (identical residues / length of longest protein) between other known formal 
[4+2] cycloaddition proteins. The gene name and resulting thiopeptide product are given. Values 
in blue indicate sequence similarity, while green represent sequence identity values.  
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Figure 4.13 
A. Gene Neighborhood Homologs 
Gene Cyclothiazomycin A 
(Streptomyces hygroscopicus 
subsp. jinggangensis 5008) 
Homolog (Species / 
Accession number) 
Cyclothiazomycin B 
(Streptomyces mobaraensis) 
Homolog (Species / Accession 
number) 
Cyclothiazomycin 
C 
Homolog (Species 
/ Accession 
number) 
1 Ferredoxin reductase 
(Streptomyces albulus / 
WP_020929831.1) 
 
ArsR family transcriptional 
regulator (Nocardiopsis 
halophila / WP_017541891.1) 
Anti-sigma b 
factor RsbV 
(Streptomyces 
rimosus / 
WP_003980648.1) 
2 Ferredoxin reductase 
(Streptomyces albulus / 
WP_016575819.1) 
Helix-turn-helix protein 
(Streptomyces purpureus / 
WP_019884370.1) 
Anti-sigma b 
factor antagonist 
RsbV 
(Streptomyces 
rimosus / 
WP_003980649.1) 
 
3 Copper domain protein 
(Streptomyces sp. FR1 / 
YP_008995649.1) 
Secreted amidase (Streptomyces 
bingchenggensis BCW-1 /  
YP_004958967.1) 
Anti-anti-sigma 
regulatory factor 
(Streptomyces 
rimosus / 
WP_003980650.1) 
 
4 Isoprenylcysteine carboxyl 
methyltransferase (Frankia sp. 
CN3 / WP_007507509.1) 
 
NAD binding lipoprotein 
(Streptomyces viridosporus / 
WP_016827948.1) 
Hypothetical 
(Streptomyces 
rimosus / 
WP_003980651.1) 
5 Hypothetical protein 
(Rhodococcus sp. DK17 / 
WP_016881545.1) 
 
Hypothetical protein 
(Streptomyces sp. MspMP-M5 / 
WP_018538980.1) 
Acyl-CoA 
dehydrogenase 
(Streptomyces sp. 
FxanaC1 / 
WP_018088719.1) 
6 Hypothetical protein 
(Rhododcoccus sp. DK17 / 
WP_016881544.1) 
Hypothetical protein  
(Streptomyces sp. 351MFTsu5.1 
/ WP_020141300.1) 
PadR-like family 
transcriptional 
regulator 
(Streptomyces 
rimosus / 
WP_003980654.1) 
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Figure 4.13 (continued) 
 
7 Transposase (Streptomyces 
coelicolor A3(2) / 
NP_639869.1) 
Putative oxidoreductase 
(Sinorhizobium meliloti SM11 / 
YP_005719396.1) 
Protein 
serine/threonine 
phosphatase 
(Streptomyces 
rimosus / 
WP_003982697.1) 
 
8 Hypothetical protein 
(Streptomyces albulus / 
WP_016576055.1) 
MFS transporter (Streptomyces 
roseochromogenes / 
WP_023546609.1) 
Cytochrome P450 
FAS1 
(Streptomyces 
rimosus / 
WP_003980657.1) 
 
9 Hypothetical protein 
(Streptomyces sp. PsTaAH-
124  / WP_018569508.1) 
Transglycosylase-associated 
protein (Streptomyces rimosus / 
WP_003987332.1) 
Aminoglycoside 
phosphotransferase 
(Streptomyces 
cattleya / 
YP_004920848.1) 
 
10 Hypothetical protein 
(Streptomyces hygroscopicus 
subsp. jinggangensis 5008 /  
YP_006249961.1) 
 
Chitinase (Streptomyces / 
WP_018524268.1) 
ABC transporter 
(Streptomyces 
rimosus / 
WP_003980658.1) 
CtmI Hypothetical protein 
(Streptomyces mobaraensis / 
WP_004943462.1) 
Putative peptidase containing 
docking domain (Streptomyces 
hygroscopicus / ACS50133.1) 
 
Putative 
peptidase 
containing 
docking domain 
(Streptomyces 
hygroscopicus / 
ACS50133.1) 
 
CtmB NADH oxidase 
(Streptomyces mobaraensis / 
WP_004943465.1) 
NADH oxidase (Streptomyces 
hygroscopicus / ACS50132.1) 
 
NADH oxidase 
(Streptomyces 
mobaraensis / 
WP_004943465.1) 
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Figure 4.13 (continued) 
 
CtmA Hypothetical protein 
(Streptomyces mobaraensis / 
WP_004943468.1) 
Hypothetical protein 
(Streptomyces hygroscopicus / 
YP_006249964.1) 
Hypothetical 
(Streptomyces 
mobaraensis / 
WP_004943468.1) 
 
CtmD Cyclodehydratase 
(Streptomyces mobaraensis / 
WP_004943471.1) 
Putative docking protein 
(Streptomyces hygroscopicus / 
ACS50130.1) 
Hypothetical 
protein 
(Streptomyces 
mobaraensis / 
WP_004943471.1) 
 
CtmE Lantibiotic dehydratase 
(Streptomyces mobaraensis / 
WP_004943473.1) 
Lantibiotic dehydratase 
(Streptomyces hygroscopicus / 
ACS50129.1) 
Lanthionine 
biosynthesis 
protein 
(Streptomyces 
mobaraensis / 
WP_004943473.1) 
 
CtmF Lantibiotic biosynthesis 
protein (Streptomyces 
mobaraensis / 
WP_004943476.1) 
Lantibiotic biosynthesis 
protein (Streptomyces 
hygroscopicus / 
YP_006249967.1) 
Lantibiotic 
biosynthesis 
protein 
(Streptomyces 
mobaraensis / 
WP_004943476.1) 
 
CtmG Hypothetical protein 
(Streptomyces mobaraensis / 
WP_004943480.1) 
 
Hypothetical protein 
(Streptomyces hygroscopicus / 
YP_006249968.1) 
Hypothetical 
protein 
(Streptomyces 
mobaraensis / 
WP_004943480.1) 
CtmJ  Hypothetical protein 
(Streptomyces auratus / 
WP_006606582.1) 
 
 
CtmK  Hypothetical protein 
(Streptomyces auratus / 
WP_006606583.1) 
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Figure 4.13 (continued) 
 
CtmH LuxR transcriptional 
regulator (Streptomyces 
mobaraensis / 
WP_004943488.1) 
LuxR transcriptional 
regulator (Streptomyces 
hygroscopicus / ACS50126.1) 
 
LuxR family 
transcriptional 
regulator 
(Streptomyces 
hygroscopicus / 
ACS50126.1) 
11 Hypothetical protein 
(Streptomyces sp. FR1 / 
YP_008995424.1) 
Integral membrane protein 
(Streptomyces avermitilis MA-
4680 / NP_828391.1) 
 
Short chain 
dehydrogenase 
(Streptomyces 
auratus / 
WP_006608143.1) 
12 Ethyl tert-butyl ether 
degradation (Streptomyces 
griseoaurantiacus / 
WP_006139146.1) 
 
Hypothetical protein 
(Streptomyces griseoflavus / 
WP_004934717.1) 
Hypothetical 
protein 
(Streptomyces 
rimosus / 
WP_003980661.1) 
13 MFS transporter 
(Streptomyces 
griseoaurantiacus / 
WP_006139145.1) 
 
LysR family transcriptional 
regulator (Streptomyces 
himastatinicus / 
WP_009713438.1) 
 
Hypothetical 
protein 
(Streptomyces 
rimosus / 
WP_003980662.1) 
14 DNA binding protein 
(Streptomyces 
griseroaurantiacus / 
WP_006139144.1) 
Ornithine carbamoyltransferase 
(Patulibacter 
medicamentivorans 
WP_007570660.1) 
Methylated DNA 
protein cysteine S-
methyltransferase 
(Streptomyces 
rimosus / 
WP_003980663.1) 
 
15 AraC family transcriptional 
protein (Streptomyces albulus 
/ WP_020930180.1) 
Hypothetical protein 
(Streptomyces mobaraensis 
WP_004943504.1) 
 
Ricin superfamily 
(Streptomyces 
rimosus / 
WP_003980666.1) 
16 Hypothetical protein 
(Streptomyces hygroscopicus 
subsp. jinggangensis 5008 / 
YP_006249975.1) 
 
Hypothetical protein 
(Amycolatopsis nigrescens / 
WP_020673411.1) 
 
Oxidoreductase 
domain protein 
(Streptomyces 
rimosus / 
WP_003980667.1) 
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Figure 4.13 (continued) 
 
17 Transposase (Streptomyces 
lividans / WP_003974545.1) 
TetR family transcriptional 
regulator (Streptomyces 
clavuligerus / 
WP_003956021.1) 
 
ArsR family 
transcriptional 
regulator 
(Streptomyces 
rimosus / 
WP_003980668.1) 
18 Transposase (Streptomyces sp. 
Mg1 / WP_008736550.1) 
Hypothetical protein 
(Streptomyces sulphureus / 
WP_019547651.1) 
 
30S ribosomal 
protein (Thauera 
terpenica / 
WP_021250332.1) 
19 Transposase (Streptomyces 
violaceusniger Tu 4113/ 
YP_004800126.1) 
Hypothetical protein 
(Streptomyces aurantiacus / 
WP_016638852.1) 
Ribosome-
inactivating 
protein 
(Streptomyces 
scabiei 87.22 / 
YP_003494282.1) 
 
20 Oxidoreductase (Streptomyces 
viridochromogenes / 
WP_003995212.1) 
Hypothetical protein 
(Streptomyces thermolilacinus / 
WP_023588110.1) 
Ricin superfamily 
(Streptomyces sp. 
Mg1 / 
WP_008735505.1) 
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Figure 4.13 (continued) 
B. Cyclothiazomycin C protein identities 
 
Protein 
(cyclothiazomycin C) 
Top BLAST hit /  
accession number 
% Identity Residues  
(aligned/total)  
CtmI 
(WC3908_03952) 
Streptomyces hygroscopicus / 
ACS50133.1 
 
60 379/634 
CtmB 
(WC3908_03953) 
Streptomyces mobaraensis / 
WP_004943465.1 
 
61 324/531 
CtmA 
(WC3908_03954) 
Streptomyces mobaraensis / 
WP_004943468.1 
 
78 43/55 
CtmD 
(WC3908_03955) 
Streptomyces mobaraensis / 
WP_004943471.1 
 
72 455/636 
CtmE 
(WC3908_03956) 
Streptomyces mobaraensis / 
WP_004943473.1 
 
58 500/858 
CtmF 
(WC3908_03957) 
Streptomyces mobaraensis / 
WP_004943476.1 
 
57 192/334 
CtmG 
(WC3908_00024) 
Streptomyces mobaraensis / 
WP_004943480.1 
 
68 265/397 
CtmH 
(WC3908_03958) 
Streptomyces hygroscopicus / 
ACS50133.1 
46 429/924 
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Figure 4.13 (continued) | Gene similarities for the cyclothiazomycin biosynthetic gene 
clusters. (A) Genes surrounding the conserved portion of the cyclothiazomycin biosynthetic gene 
clusters were used as query sequences to identify homologs via BLAST searching. Genes 1-10 
represent the genes upstream of the conserved cluster with 1 being the farthest from ctmI. CtmI – 
H are the conserved genes in the clusters (Figure 3b, NCBI accession number KJ651958) and are 
highlighted in gray. Red denotes ctmG from the cyclothiazomycin C producer that is conserved, 
but not present in the gene cluster, but rather elsewhere in the genome. Genes 11-20 lie downstream 
of the conserved region. (B) BLAST results using the conserved genes from the cyclothiazomycin 
C gene cluster as query sequences. The best match returned by BLAST and the percent identities 
are given.  
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Table 4.1 | Antimicrobial activity of cyclothiazomycin B and C toward a panel of diverse 
bacteria and fungi. 
Speciesa MICb, 
cyclothiazomycin B  
MICb, 
cyclothiazomycin C  
Bacillus anthracis 
Bacillus subtilis 
Enterococcus faecalis 
Listeria monocytogenes 
Staphylococcus aureus  
Escherichia coli 
Neisseria sicca  
Pseudomonas putida 
Aspergillus niger 
Fusarium virguliforme 
Saccharomyces cerevisiae 
Talaromyces stipitatus 
    1 
    2 
  32 
    8 
    4 
  64 
>64 
>64 
>64 
  64 
  64 
  64 
   1 
   4 
32-64 
  16 
  16 
>64 
>64 
>64 
>64 
>64 
>64 
>64 
 
aThe top five species are Gram positive bacteria from the Firmicutes phylum. The next three species 
are Gram negative bacteria from the Proteobacteria phylum. The lowest 4 species are fungi from 
the Ascomycota phylum. bAll minimum inhibitory concentrations (MIC) were determined by the 
microbroth dilution method and are presented in µg/mL. 
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APPENDIX A: FURTHER PUBLICATIONS WITH MINOR CONTRIBUTIONS 
 
A.1 Discovery of a New ATP-Binding Motif Involved in Peptidic Azoline Biosynthesis 
 
This chapter was reprinted with permission from Dunbar, Chekan, cox, Burkhart, Nair, 
and Mitchell (Dunbar, et al. 2014).  
I aided in the collection, interpretation and figure generation for the bioinformatics 
analysis of the YcaO superfamily. This included supplemental figures 5 and 6. 
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A.2 HIV Protease Inhibitors Block Streptolysin S Production   
This chapter was reprinted with permission from Maxson, Deane, Molloy, Cox, Markley, 
Lee, and Mitchell (Maxson, et al. 2015). 
I aided in the collection and interpretation of the bioinformatic analysis for the number of 
CaaX-like proteases located within TOMM biosynthetic gene clusters. 
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A.3 Undecaprenyl Diphosphate Synthase Inhibitors: Antibacterial Drug Leads 
 
This chapter was reprinted with permission from Sinko, Wang, Zhu, Feixas, Cox, 
Mitchell, Oldfield, and McCammon (Sinko, et al. 2014).  
I aided in the collection, interpretation and figure generation for the MIC and synergistic 
activity of the compounds. 
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